Transcat Inc DEF 14A, filed Jul 24, 2025
Transcat Inc (TRNS)
About this DEF 14A
Transcat Inc filed this DEF 14A on July 24, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934 (Amendment No. )
| Filed by the Registrant ☒ | ||
| Filed by a party other than the Registrant ☐ | ||
| Check the appropriate box: | ||
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☒ | Definitive Proxy Statement | |
| ☐ | Definitive Additional Materials | |
| ☐ | Soliciting Material under §240.14a-12 | |
| (Name of Registrant as Specified In Its Charter) | ||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||
| Payment of Filing Fee (Check all boxes that apply): | ||
| ☒ | No fee required | |
| ☐ | Fee paid previously with preliminary materials | |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |
TRANSCAT, INC.
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
| When: Wednesday, September 10, 2025 12:00 p.m. Eastern Time |
Where: Via webcast at www.virtualshareholdermeeting.com/TRNS2025 |
Record Date: July 14, 2025 |
| Items of Business | Board Recommendation | |
| ► Proposal 1: Election of director nominees | For each nominee | |
| ► Proposal 2: To fix the number of directors constituting the board of directors at nine | For | |
| ► Proposal 3: To approve, on an advisory basis, the compensation of our named executive officers | For | |
| ► Proposal 4: To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers | For “ONE YEAR” | |
| ► Proposal 5: To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 28, 2026 | For | |
| To transact such other business as may properly come before the meeting or any adjournment or postponement thereof. | ||
Voting: Holders of Transcat, Inc. common stock at the close of business on the Record Date are entitled to vote. Whether or not you expect to participate in the Annual Meeting, please grant a proxy to vote by one of the following procedures as promptly as possible in order to ensure your representation at the Annual Meeting. If you own your shares through a broker, we encourage you to follow the instructions provided by your broker about how to vote. Unless you provide your broker with voting instructions, your broker may not vote your shares on Proposals 1, 2, 3, and 4.
| Prior to the Meeting: | |||
| By Internet* www.proxyvote.com |
By Smartphone or Tablet Vote your shares by scanning the QR code provided on the Notice of Internet Availability or proxy card (if you request one) |
By Telephone* 1-800-690-6903 |
By Mail Complete, date, sign and return the proxy card mailed to you (if you request one) or voting instruction card (if sent by your nominee) |
| During the Meeting: | |||
| By Internet* www.virtualshareholdermeeting.com/TRNS2025 | |||
* You will need to provide the control number that appears on your Notice of Internet Availability of Proxy Materials, proxy card or voting instruction form. Voting by telephone, internet, smartphone and tablet closes on September 9, 2025 at 11:59 p.m. Eastern Time.
| By Order of the Board of Directors | |
| Thomas L. Barbato | |
| Senior Vice President of Finance and Chief Financial Officer |
Rochester, New York
July 24, 2025
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE Our Proxy Statement and Annual Report to Shareholders are available online at www.proxyvote.com |
i
TABLE OF CONTENTS
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS: This proxy statement contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations, estimates, beliefs, assumptions and predictions of future events and are identified by words such as “believes,” “estimates,” “expects,” “seek,” “strategy,” “target,” “could,” “may,” “will,” “would,” “intend,” “designed,” “focus,” and other similar words. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical results or those expressed in such forward-looking statements. You should evaluate forward-looking statements in light of important risk factors and uncertainties that may affect our operating and financial results and our ability to achieve our financial objectives. These risk factors and uncertainties are more fully described by us under the heading “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K. You should not place undue reliance on our forward-looking statements, which speak only as of the date they are made or as indicated. Except as required by law, we undertake no obligation to update or publicly announce any revisions to any of the forward-looking statements, whether as a result of new information, future events or otherwise.
NOTE ABOUT OUR WEBSITES AND REPORTS: None of the statements on our websites or reports referenced or discussed in this proxy statement, are deemed to be part of, or incorporated by reference into, this proxy statement. The statements and reports may also change at any time, and we undertake no obligation to update them, except as required by law.
ii
TRANSCAT, INC.
35 Vantage Point Drive, Rochester, New York 14624
PROXY STATEMENT FOR THE ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON SEPTEMBER 10, 2025
PROXY STATEMENT SUMMARY
To assist you in reviewing the proposals to be considered and voted upon at our annual meeting of shareholders (the “Annual Meeting”) to be held on September 10, 2025, we have summarized information contained elsewhere in this proxy statement or in our Annual Report to Shareholders for the fiscal year ended March 29, 2025, which includes our annual report on Form 10-K (the “Annual Report”). This summary does not contain all of the information you should consider about Transcat, Inc. (the “Company,” “we,” “our,” “Transcat”) and the proposals being submitted to shareholders at the Annual Meeting. We encourage you to read the entire proxy statement and Annual Report carefully before voting.
The Annual Meeting
|
When: Wednesday, September 10, 2025 12:00 p.m. Eastern Time |
Where: Via webcast at www.virtualshareholdermeeting.com/TRNS2025 |
Record Date: July 14, 2025 |
Meeting Agenda and Voting Matters
| Proposal | Board Vote Recommendation |
Page Reference | |
| 1. | Election of three director nominees | FOR each nominee | 7 |
| 2. | To fix the number of directors constituting the board of directors at nine | FOR | 1 |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers | FOR | 2 |
| 4. | To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers | FOR “ONE YEAR” | 3 |
| 5. | To ratify the selection of Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for the fiscal year ending March 28, 2026 | FOR | 4 |
Directors and Director Nominees
| Name | Age | Recent Professional Experience | Committees |
| Craig D. Cairns* | 60 | President of Howe & Rusling, Inc. | CC** |
| Dawn G. DePerrior*t | 67 | Retired Managing Director in EY’s Healthcare Technology Consulting Practice |
CC, TC |
| Oksana S. Dominach* | 61 | Senior Vice President, Beer Finance of Constellation Brands, Inc. |
AC**, CC, EC |
| Christopher P. Gillette* | 64 | Lean Leader Sales & Marketing of GE Aviation | NESGC, TC |
| Charles P. Hadeed* | 75 | Former Chairman, President and Chief Executive Officer of the Company |
AC, EC |
1
| Name | Age | Recent Professional Experience | Committees |
| Gary J. Haseley* | 63 | Chairman of Board of the Company; Retired Senior Vice President and General Manager of Kaman Automation, Control & Energy |
EC** |
| Mbago M. Kaniki* | 47 | Chief Executive Officer of Adansonia Management LLC |
NESGC**, CC, EC |
| Robert L. Mecca*t | 54 | Senior Vice President of Finance at Gilead Sciences |
AC |
| Cynthia M. Langston*t | 64 | Senior Vice President and Chief Information Officer at Excellus BlueCross BlueShield |
TC**, AC, NESGC |
| Lee D. Rudow | 61 | President and Chief Executive Officer of the Company |
EC |
| t | — Director Nominee | AC | — Audit Committee | EC | — Executive Committee |
| * | — Independent | CC | — Compensation Committee | TC | — Technology Committee |
| ** | — Chair | NESGC | — Nominating, Environmental, Social and Governance Committee | ||
Our Business
We are a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation. We are focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly. We conduct our business through two operating segments: service (“Service”) and distribution (“Distribution”).
Company Governance Highlights
Operating Priorities. Our fiscal year ended March 29, 2025 (“fiscal 2025”) was highlighted by mid to high single digit revenue growth across both segments. During fiscal 2025, we completed two acquisitions: Martin Calibration, Inc, a privately-held Minnesota calibration services company; and Becnel Rental Tools, LLC, a privately-held Louisiana provider of rental tools and services used in the decommission and maintenance of oil wells. These acquisitions have expanded our geographic reach, continued to expand our addressable markets, and widened the breadth of our service offerings. We believe our acquisition strategy continues to be a differentiator for us.
Board of Directors. All members of our Board of Directors (the “Board”), except for our President and Chief Executive Officer, Lee Rudow, are considered independent directors. Our Board is composed of talented directors with diverse skill sets. We believe ongoing evaluation and board refreshment are critical for us to execute our long-term strategy and maximize shareholder value. At our 2024 Annual Meeting, we sought and received shareholder approval to declassify the Board with 99% of the votes cast approving that proposal. Beginning with this Annual Meeting, each director nominee elected at an annual meeting will be elected for a one-year term until their respective successors have been duly elected and qualified. As a result, by the annual meeting of shareholders held in 2028, our Board will no longer be classified.
Corporate Governance Guidelines. In May, our Board adopted Corporate Governance Guidelines which reflect the Board's commitment to monitor the effectiveness of policy and decision-making both at the Board and management level, with a view to enhancing long-term shareholder value. A copy of these guidelines can be found on our website, Transcat.com, under the heading “Investor Relations” and the subheading “Corporate Governance.”
2
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS
Why am I receiving these proxy materials?
The Board is providing these proxy materials in connection with the solicitation by the Board of proxies for use at the Annual Meeting, or at any adjournment of the meeting, for the purposes set forth in this proxy statement. The proxy materials are being made available to you on the internet, or by printed versions if requested and delivered to you by mail.
The Annual Meeting will be held virtually by means of a live webcast. You will be able to attend the Annual Meeting, vote your shares and submit questions during the meeting via the internet by visiting www.virtualshareholdermeeting.com/TRNS2025. There will not be a physical meeting location and you will not be able to attend in person. We invite you to attend the Annual Meeting and request that you vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. See “How do I vote?” below.
What is included in these proxy materials?
These proxy materials include:
| · | Our Annual Report for fiscal 2025; and |
| · | Notice of 2025 Annual Meeting and Proxy Statement. |
If you request and receive printed versions of the proxy materials by mail, these proxy materials also include a proxy card.
Why did I receive a one-page notice in the mail regarding the internet availability of proxy materials instead of a full set of proxy materials?
We are following the “e-proxy” rules of the Securities and Exchange Commission (the “SEC”) that allow public companies to furnish proxy materials to shareholders over the internet. These rules remove the requirement for public companies to automatically send shareholders a full, printed copy of proxy materials and allow them instead to deliver to their shareholders a Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”) and to provide online access to the proxy materials. Accordingly, we mailed the Notice of Internet Availability to our shareholders of record on or about July 24, 2025.
The Notice of Internet Availability provides instructions on how to:
| · | View our proxy materials for the Annual Meeting on the internet and vote; and |
| · | Request a printed copy of the proxy materials. |
In addition, shareholders may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. Choosing to receive your future proxy materials by email will save us the cost of printing and mailing documents to you and will reduce the environmental impact of printed materials.
Where can I view the proxy materials on the internet?
You may view the proxy materials and Annual Report at www.virtualshareholdermeeting.com/TRNS2025. Our annual report on Form 10-K for fiscal 2025, as filed with the SEC, is included in the Annual Report and includes our audited consolidated financial statements, along with other information about us, which we encourage you to read.
3
How can I receive a printed copy of the proxy materials, including the Annual Report?
Shareholder of Record. You may request a printed copy of the proxy materials by any of the following methods:
| · | Telephone: call toll-free at 1-800-579-1639; |
| · | Internet at www.proxyvote.com; or |
| · | Email at sendmaterial@proxyvote.com with your control number (the number located in the shaded bar on the reverse side of the Notice of Internet Availability) in the subject line. In the message, include your full name and address, and state that you want to receive a paper copy of current and/or future proxy materials. |
Beneficial Owner. You may request a printed copy of the proxy materials by following the instructions provided to you by your broker, bank or nominee.
Who can vote at the Annual Meeting?
Each holder of shares of our common stock at the close of business on July 14, 2025, the record date (the “Record Date”) for the Annual Meeting, is entitled to notice of and to vote at the Annual Meeting. We have one class of shares outstanding, designated common stock, $0.50 par value per share. As of the Record Date, there were 9,318,490 shares of our common stock issued and outstanding.
What is the quorum requirement?
A quorum is required for shareholders to conduct business at the Annual Meeting. According to our Code of Regulations, as amended (the “Code of Regulations”), the holders of a majority of the issued and outstanding shares of our common stock present in person or by proxy at the meeting will constitute a quorum.
How many votes are needed to approve each proposal and what are the recommendations of the Board?
The table below shows the vote required to approve each of the proposals described in this proxy statement, assuming the presence of a quorum, in person or by proxy, at the Annual Meeting.
| Proposal | Description | Vote Required | Board Recommendation |
Effect of Abstentions |
Effect of Broker Non-Votes | |||||
| One | Election of three director nominees |
Plurality of the votes duly cast at the Annual Meeting (1)
|
For each nominee | None | None | |||||
| Two | To fix the number of directors constituting the board of directors at nine | Majority of the shares which are represented at the Annual Meeting | For | Against | Against | |||||
| Three | To approve, on an advisory basis, the compensation of our named executive officers |
Majority of the votes duly cast at the Annual
|
For | None | None |
4
| Proposal | Description | Vote Required | Board Recommendation |
Effect of Abstentions |
Effect of Broker Non-Votes | |||||
| Four | To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers |
Plurality of the votes duly cast at the Annual Meeting (2)
|
For “ONE YEAR” | None | None | |||||
| Five | To ratify the selection of Deloitte as our independent registered public accounting firm for the fiscal year ending March 28, 2026 | Majority of the votes duly cast at the Annual Meeting (3) |
For | None | Not applicable since this proposal is a routine matter on which brokers may vote |
| (1) | Under our “plurality” voting standard, votes to “withhold” a vote will have no effect on the outcome of the vote, because nominees who receive the highest number of “for” votes will be elected. |
| (2) | The results of the advisory vote to approve the compensation of our named executive officers and the frequency of future advisory votes on the compensation of our named executive officers are not binding on the Board or the Compensation Committee. However, the Board and the Compensation Committee value the opinions expressed by our shareholders in their votes on these proposals and will consider the outcome of the votes when making future compensation decisions regarding our named executive officers. |
| (3) | We are presenting the selection of Deloitte as our independent registered public accounting firm to our shareholders for ratification. The Audit Committee will consider the outcome of this vote when selecting our independent registered public accounting firm for subsequent fiscal years. |
Can I attend the Annual Meeting in person?
No. We will be hosting the Annual Meeting only by means of a live webcast. There will not be a physical meeting location and you will not be able to attend the meeting in person. We believe that hosting a virtual meeting will enable greater shareholder attendance and participation from any location. Please be assured that you will be afforded the same rights and opportunities to participate in the virtual meeting as you would at an in-person meeting. You will be able to listen to the Annual Meeting, submit questions and vote by going to www.virtualshareholdermeeting.com/TRNS2025. If you wish to listen to the Annual Meeting, but do not wish to submit questions or vote during the Annual Meeting, you may log in as a guest at www.virtualshareholdermeeting.com/TRNS2025.
The Annual Meeting webcast will start at 12:00 p.m., Eastern Time, on Wednesday, September 10, 2025. We encourage you to access the meeting website prior to the start time to allow time for check in. If you encounter technical difficulties accessing our Annual Meeting, a support line will be available on the login page of the virtual meeting website shortly before the beginning of the Annual Meeting.
As always, we encourage you to vote your shares prior to the Annual Meeting.
Do I need to register to attend the Annual Meeting?
You do not need to register to attend the Annual Meeting webcast. Follow the instructions on your Notice of Internet Availability or proxy card (if you requested and received a printed copy of the proxy materials) to access the Annual Meeting.
5
How do I ask questions at the Annual Meeting?
If you wish to submit a question the day of the Annual Meeting you may log into the virtual meeting platform at www.virtualshareholdermeeting.com/TRNS2025, type your question into the “Ask a Question” field and click “Submit.”
Questions pertinent to meeting matters will be answered during the Annual Meeting, subject to time constraints. Questions regarding personal matters, including those related to employment, are not pertinent to Annual Meeting matters and therefore will not be answered.
How do I vote?
Shareholder of Record: Shares Registered in Your Name. If on the Record Date, your shares of our common stock were registered directly in your name with our transfer agent, Computershare, then you are a shareholder of record. If you are a shareholder of record, there are five ways to vote:
| · | By internet at www.proxyvote.com. |
| · | By using your smartphone or tablet and scanning the QR code provided on the Notice of Internet Availability or proxy card if you received one. |
| · | By touch tone telephone: call toll-free at 1-800-690-6903. |
| · | By completing and mailing your proxy card (if you requested and received a printed copy of the proxy materials). |
| · | At the Annual Meeting: instructions on how to vote during the Annual Meeting webcast are posted at www.virtualshareholdermeeting.com/TRNS2025. Votes submitted during the Annual Meeting must be received no later than the closing of the polls at the Annual Meeting. |
Whether or not you plan to attend the meeting, we urge you to vote to ensure your vote is counted. You may still attend the meeting and vote your shares if you have already voted by proxy. Only the latest vote you submit will be counted.
Beneficial Owner: Shares Registered in the Name of Broker or Bank. If, on the Record Date your shares of our common stock were held in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in “street name” and these proxy materials are being made available to you by that organization along with a voting instruction card. As a beneficial owner, you must vote your shares in the manner prescribed by your broker, bank or nominee (“broker”). Your broker has enclosed or otherwise provided a voting instruction card for you to use in directing the broker how to vote your shares. Check the voting instruction card used by that organization to see if it offers internet or telephone voting.
Instead of directing your broker how to vote your shares, you may elect to attend the Annual Meeting and vote your shares during the meeting. To do so, contact your broker at least five days before the Annual Meeting to obtain a control number or legal proxy to vote your shares during the meeting. If you have any questions about your control number or how to obtain one, please contact your broker. Instructions on how to vote during the Annual Meeting webcast are posted at www.virtualshareholdermeeting.com/TRNS2025. Votes submitted during the Annual Meeting must be received no later than the closing of the polls at the Annual Meeting.
How many votes do I have?
Each shareholder is entitled to one vote for each share of common stock held as of the Record Date. You may either vote “FOR” or “WITHHOLD” authority to vote for our nominees for the Board in Proposal One. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal Two (to fix the number of directors at nine), Proposal Three (advisory vote to approve the compensation of our named executive officers), and Proposal Five (to ratify the selection of our independent registered public accounting firm). You may vote “ONE YEAR,” “TWO YEARS,” “THREE YEARS” or “ABSTAIN” on Proposal Four (advisory vote to determine the frequency of future advisory votes on the compensation of our named executive officers).
6
What happens if I do not give specific voting instructions?
Shareholder of Record. If you are a shareholder of record and you (i) indicate when voting on the internet or by telephone that you wish to vote as recommended by the Board, or (ii) sign and return a proxy card without giving specific voting instructions, then the named proxies will vote your shares in the manner recommended by the Board (i.e., FOR each of the director nominees named in Proposal One, FOR Proposals Two, Three, and Five, and for ONE YEAR for Proposal Four) and in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting or at any adjournment or postponement of the meeting.
Beneficial Owner. If you do not provide your broker with specific voting instructions, or if you do not vote the shares at the Annual Meeting, your shares will not be voted or counted with respect to Proposals One, Two, Three, and Four which are non-routine proposals. Your broker has discretionary authority to vote your uninstructed shares with respect to Proposal Five, which is a routine proposal.
What effect do abstentions have?
An abstention represents a shareholder’s affirmative choice to decline to vote on a proposal, other than the election of directors. Shares that abstain from voting on a proposal are counted for the purpose of determining the presence of a quorum but are not considered votes “duly cast” for a proposal. Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Three, Four, and Five), because abstentions are not counted as votes duly cast. However, abstentions will have the effect of a vote against a proposal requiring the vote of a majority of the shares represented at the meeting (Proposal Two), because abstentions are not affirmative votes.
What happens if I do not cast a vote and what are broker non-votes?
If you are a shareholder of record and you do not cast your vote, no votes will be cast on your behalf on any of the items of business at the Annual Meeting.
If you hold your shares in street name and do not provide voting instructions to your broker, your broker may still be able to vote your shares with respect to certain “discretionary” (or routine) items but will not be allowed to vote your shares with respect to certain “non-discretionary” (or non-routine) items. In the case of non-discretionary items, for which no instructions are received, the shares will be treated as “broker non-votes.” Shares that constitute broker non-votes will be counted as present at the Annual Meeting for the purpose of determining a quorum. A broker will have discretionary authority to vote on Proposal Five relating to the ratification of the selection of our independent registered public accounting firm but will not have discretionary authority to vote on any other matter. As a result, if you do not vote your street name shares, your broker has the authority to vote on your behalf with respect to Proposal Five (the ratification of the selection of the independent registered public accounting firm), but not with respect to Proposal One (the election of directors), Proposal Two (to fix the number of directors at nine), Proposal Three (advisory vote to approve the compensation of our named executive officers), and Proposal Four (advisory vote to determine the frequency of future advisory votes on the compensation of our named executive officers). Broker non-votes will have no effect on the outcome of Proposals One, Three, and Four. Broker non-votes will count as a vote against Proposal Two. We encourage you to provide instructions to your broker to vote your shares on Proposals One, Two, Three, and Four.
7
Can I change my vote or revoke my proxy?
You may change your vote or revoke your proxy at any time before it is voted at the Annual Meeting.
If you are a shareholder of record, you may change your vote or revoke your proxy in any one of the following ways:
| · | You may submit a later-dated vote by internet or telephone (only your latest internet or telephone vote will be counted); |
| · | You may submit another timely, properly completed, later-dated proxy card; |
| · | You may send a timely written notice that you are revoking your proxy to our Corporate Secretary, 35 Vantage Point Drive, Rochester, New York 14624, which must be received no later than September 9, 2025; or |
| · | You may attend the Annual Meeting webcast and vote during the meeting. Attending the meeting without voting during the meeting will not, by itself, revoke a previously submitted proxy unless you specifically request your prior proxy be revoked. |
If you hold your shares in street name, please contact your broker or other organization regarding how to revoke your instructions and change your vote. You may change your vote by submitting a later-dated vote on the internet or by telephone, if offered, or by participating in the Annual Meeting webcast and by submitting a later vote during the meeting.
Who is paying for the solicitation of the proxies?
The Board is soliciting proxies for use at the Annual Meeting and we will bear the cost of the proxy solicitation. In addition to the posting or mailing of the proxy materials, our directors, officers and employees may solicit proxies personally, by telephone, by email or by other means of communication. We will not compensate any of these persons for soliciting proxies on our behalf. We will reimburse brokerage firms and other persons representing beneficial owners of shares for their expenses in forwarding solicitation material to such beneficial owners.
How can I find out the voting results of the Annual Meeting?
Preliminary voting results will be announced at the Annual Meeting. Final voting results will be published in a Current Report on Form 8-K to be filed with the SEC within four business days after the Annual Meeting.
How can I obtain a copy of the annual report on Form 10-K?
You can obtain upon request, free of charge, a copy of our annual report on Form 10-K for fiscal 2025 by:
| · | accessing our website, Transcat.com, and going to “SEC Filings” under “Investor Relations”; |
| · | writing to us at: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary; or |
| · | telephoning us at (585) 352-7777. |
You can also obtain a copy of our annual report on Form 10-K for fiscal 2025 and all other reports and information that we file with, or furnish to, the SEC from the SEC’s EDGAR database at www.sec.gov.
Information included on our website is not part of this proxy statement.
8
PROPOSAL
ONE:
ELECTION OF DIRECTORS
Our Code of Regulations currently provides for a classified Board consisting of three classes of directors, each serving staggered three-year terms. Beginning with this Annual Meeting, each director nominee elected at an annual meeting will be elected for a one-year term and until their respective successors have been duly elected and qualified. As a result, only a portion of our Board will be elected each year prior to the annual meeting of shareholders held in 2028, when our Board will no longer be classified. The term of four of our directors will expire at this year’s Annual Meeting.
Based on the recommendation of the Nominating, Environmental, Social and Governance Committee (the “NESG Committee”), we have nominated Dawn G. DePerrior, Cynthia M. Langston and Robert L. Mecca, each to serve for a one-year term expiring in 2026 or until his or her successor is duly elected and qualified. Unless authority to vote for one of the nominees is specifically withheld, proxies will be voted FOR the election of Mses. DePerrior and Langston and Mr. Mecca. On July 16, 2025, Mr. Hadeed notified us of his intention to retire from the Board effective as of August 1, 2025. We thank Mr. Hadeed for the insight and significant contributions he has provided during his twenty-three years of distinguished service to Transcat and wish him the best.
The Board recommends that you vote FOR the election of each of Mses. DePerrior and Langston and Mr. Mecca.
We do not contemplate that any of the nominees will be unable to serve as a director, but if that contingency should occur prior to the voting of the proxies, the persons named in the proxy reserve the right to vote for such substitute nominee or nominees as they, in their discretion, determine, provided that proxies cannot be voted for a greater number of persons than the number of nominees named in this proxy statement.
Board Skills Matrix
We believe that our directors and our director nominees possess the requisite experience and skills necessary to carry out their duties and to serve our best interests and those of our shareholders. The matrix below outlines the experience and skills of our directors. We have also provided a discussion in a separate paragraph immediately below the biographical information of each nominee and director whose term extends past the Annual Meeting.
| Cairns | DePerrior | Dominach | Gillette | Hadeed | Haseley | Kaniki | Langston | Mecca | Rudow | TOTAL | |
| Accounting and Internal Controls | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| Corporate Finance and Economics | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| Cybersecurity | ✓ | ✓ | ✓ | 3 | |||||||
| ESG | ✓ | ✓ | 2 | ||||||||
| Human Resources/Compensation | ✓ | ✓ | ✓ | 3 | |||||||
| Industry Experience | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| International Operations Management | ✓ | ✓ | 1 | ||||||||
| Leadership Experience | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 10 |
| Marketing | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Mergers & Acquisitions | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | |||
| Operations | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | |||
| Other Public Company Experience | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Risk Management | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| Strategic Planning | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 10 |
| Technology | ✓ | ✓ | ✓ | ✓ | 4 |
9
Nominees Proposed for Election as Directors
| Dawn G. DePerrior | |
|
Age: 67 Director since: 2023 |
Board Committee: Compensation Technology |
| Ms. DePerrior retired as a managing director in Ernst & Young’s (EY’s) healthcare technology consulting practice in June 2022. A digital leader during her 40-year career, Ms. DePerrior has command of all aspects of Information Technology (IT) including strategy, business transformation, cyber security, digitization, data, analytics, innovation, mergers and acquisition integration, and finance. Her business technology career is uniquely defined by its breadth and depth of experience, including as a consultant and internal senior leader in manufacturing, distribution, consumer product goods, healthcare, and finance, enabling her to bring creative ideas, think “out of the box”, and inspire large teams to solve strategic business problems. Prior to EY, Ms. DePerrior led business information technology transformation teams at Constellation Brands and the University of Rochester Medical Center. Ms. DePerrior was previously the board chair for the Villa of Hope, a Rochester based family services organization, and currently serves on the nominating committee. She is also a member of the board of directors for North Coast Holdings. Ms. DePerrior also served as a member of the board of directors of Evans Bancorp Inc. (formerly NYSE:EVBN) from May 2023 until its merger into NBT Bancorp Inc., in May 2025. | |
| Experience and Qualifications | |
| Ms. DePerrior’s experience in leading business technology strategy and subsequent execution of complex business transformation programs powered by innovative technology uniquely positions her to support Transcat’s strategic plan and growth. Her broad and deep leadership experience in business technology strategy, cyber, risk, data and analytics adds value as we continue the advancement of our technology strategy. | |
10
| Cynthia M. Langston | |
|
Age: 64 Director Since: 2022 |
Board Committee: Audit NESG Technology (Chair) |
| Ms. Langston joined Excellus BlueCross BlueShield in 2014 and has served as its Senior Vice President and Chief Information Officer since July 2021, having previously served in advancing positions including most recently as Senior Vice President, Chief Analytics and Data Officer from July 2017 to July 2021 and Vice President, Enterprise Project Delivery Organization from 2014 to July 2017. Ms. Langston is also Chair of the board of directors of the YWCA of Rochester & Monroe County. | |
| Experience and Qualifications | |
| Ms. Langston brings to the Board extensive experience in enterprise strategy, information technology, cybersecurity and analytics across several major industries, as well as globally. Her qualifications for election to the Board include her extensive operational, technology and risk management expertise. Ms. Langston also brings deep management and leadership experience to the Board, having held several senior leadership positions during her career. | |
| Robert L. Mecca | |
Age: 54 Director Since: 2024 |
Board Committee: Audit |
| Mr. Mecca is the Senior Vice President of Finance at Gilead Sciences, Inc. (Nasdaq: GILD), a leader in the life sciences industry. Mr. Mecca brings more than two decades of US and international life science industry experience in both biotech and large pharma. From July 2021 to July 2023, Mr. Mecca served as Senior Vice President of Finance at BeiGene USA (BeiGene), an oncology biotechnology company. Prior to his time at BeiGene, Mr. Mecca was Senior Vice President of Commercialization Finance at Bristol Myers Squibb, a global pharmaceutical company, where he held a series of expanding financial executive leadership positions with responsibilities for global manufacturing, international commercialization, R&D and business development. Mr. Mecca started his career as a technology & risk management consultant at Arthur Andersen LLP, an accounting firm. Mr. Mecca earned a master of business administration with a concentration in finance from The Wharton School of the University of Pennsylvania and a bachelor of administration in accounting from Loyola University in Maryland. Mr. Mecca served on the board of directors of the Emmanuel Cancer Foundation from June 2018 through December 2024. |
| Experience and Qualifications |
| Mr. Mecca brings to the board more than 25 years of financial experience in the life sciences industry with expertise in financial management, strategy development, business expansion and M&A. His extensive experience leading organizations through stages of growth and transformation are valuable to the board as we optimize our operations and continue our growth. |
Directors Whose Terms Do Not Expire at the 2025 Annual Meeting
| Craig D. Cairns | |
|
Age: 60 Director since: 2021 Term expires: 2027 |
Board Committee: Compensation (Chair) |
| Mr. Cairns has served as the President since May 2003 and is the majority owner of Howe & Rusling, Inc., a wealth management services company. Mr. Cairns has more than 25 years of investment experience. Mr. Cairns currently serves as the Vice Chairman of the board of trustees of McQuaid Jesuit High School and is also the Chair of the Investment Committee for the Veterans’ Outreach Center. | |
11
| Experience and Qualifications |
| Mr. Cairns brings to the Board extensive leadership experience and considerable experience with client relations, capital allocation, sales and marketing. His experience with strategic planning and execution provides us with valuable knowledge as we continue to implement our growth strategy. |
| Oksana S. Dominach | |
|
Age: 61 Director since: 2019 Term expires: 2027 |
Board Committees: Audit (Chair) Compensation Executive |
| Ms. Dominach is Senior Vice President, Beer Finance of Constellation Brands, Inc. (NYSE: STZ), a leading international producer and marketer of beer, wine and spirits. She was elected Vice President in 2004 and promoted to the Senior Vice President role in February 2016, and elected Assistant Treasurer in 2004 and promoted to Treasurer in June 2015. Previously, she served as Finance Director from 2003 to 2004. Ms. Dominach currently serves as treasurer and director of the not-for-profit Board of Constellation – Marvin Sands Performing Arts Center; a director of the Directors Advisory Council of the Rochester Division of Manufacturers and Traders Trust Company; a director of various Constellation subsidiaries; and a director of North Coast Holdings, Inc., and Lewis Tree Service, Inc. | |
| Experience and Qualifications | |
Ms. Dominach brings to the Board more than 35 years of experience and expertise in financial strategy and risk management, as well as over ten years of experience participating on public and not-for-profit boards. Her capital structure management, risk management and corporate compliance expertise provide us with valuable insight and acumen as we continue to advance our growth strategy.
| |
| Christopher P. Gillette | |
|
Age: 64 Director since: 2023 Term expires: 2026 |
Board Committees: NESG Technology |
| Mr. Gillette has served as Lean Leader Sales & Marketing of GE Aerospace, a world-leading provider of jet and turboprop engines, components and integrated systems for commercial, military, business and general aviation aircraft, since January 2022. He served as VP Commercial Excellence at GE Digital, a software and Industrial Internet of Things service provider, from July 2020 to January 2022. From April 2015 to July 2020, Mr. Gillette held various senior positions at Philips, a focused leader in health technology. | |
| Experience and Qualifications | |
Mr. Gillette brings to the Board extensive leadership and calibration industry experience, and considerable experience with client relations, sales and marketing. This experience, along with his strategic planning and market development experience, provide the Board with valuable knowledge as we continue to implement our growth strategy.
| |
| Gary J. Haseley | |
|
Age: 63 Director since: 2015 Term expires: 2026 |
Board Committee: Executive (Chair) |
| Mr. Haseley has served as the Chairman of our Board since September 2020. He served as the Senior Vice President and General Manager of Kaman Automation, Control & Energy, a division of Kaman Corporation (NYSE: KAMN), a manufacturer in the aerospace industry and the third largest distributor in the power transmission/motion control market, until his retirement in November 2016. Prior to joining Kaman, from January 2001 to August 2012, Mr. Haseley served as President and Chief Executive Officer of Zeller Corporation, a distributor of electrical and automation components and | |
12
| solutions, which Kaman acquired in 2012. From 1995 until 2001, Mr. Haseley served as Zeller’s Vice President of Sales. Prior to joining Zeller, Mr. Haseley held various engineering and sales positions. From May 2018 until December 2019, Mr. Haseley served on the board of directors of Jerash Holdings (US), Inc. (Nasdaq: JRSH). Mr. Haseley has also served on the board of directors of several other for-profit and not-for-profit entities. |
| Experience and Qualifications |
| Mr. Haseley brings extensive knowledge in the distribution and services markets to our Board. His role as Chief Executive Officer of Zeller Corporation and subsequent operational and sales roles at Kaman provide the Board with valuable insights into the leveraging of two market segments similar in synergies to our industry segments. |
| Mbago M. Kaniki | |
|
Age: 47 Director since: 2021 Term expires: 2026 |
Board Committees: NESG (Chair) Compensation Executive |
| Mr. Kaniki has served as Chief Executive Officer of Adansonia Management LLC, an investment firm, since March 2013. He was Chief Executive Officer of Alva Charge LLC, an electric vehicle charging company, from May 2016 to April 2021. Mr. Kaniki worked for other investment firms from 2001 to 2013. He has served on the board of directors of for-profit and not-for-profit entities. | |
| Experience and Qualifications | |
Mr. Kaniki has had valuable experience with numerous complex transactions, including debt and equity financings, and mergers and acquisitions. His extensive leadership experience and expertise in driving business growth and transformation through effective strategic planning and execution are valuable to the Board as the Company continues to implement its growth strategy.
| |
| Lee D. Rudow | |
|
Age: 61 Director since: 2015 Term expires: 2027 |
Board Committee: Executive |
| Mr. Rudow joined us in November 2011 as our Chief Operating Officer and was appointed President in September 2012. He was appointed Chief Executive Officer in July 2013. From 2008 until 2011, Mr. Rudow served as Vice President in various capacities for SIMCO Electronics, Inc., an independent provider of global calibration, repair and software solutions. Prior to that, from 2006 to 2008, he was President and Chief Executive Officer of Davis Calibration, Inc., served as President and Chief Executive Officer of its related business and predecessor, Davis Inotek Corp. from 1996 to 2006, and served as President of Davis Instruments Corp. from 1986 to 1996. | |
| Experience and Qualifications | |
| Mr. Rudow brings more than 35 years of experience in both of our industry segments. He has a strong understanding of the execution needed for our current business strategy and has served in sales, sales management and operational positions at Transcat and our competitors. Mr. Rudow has worked at startups, private equity-funded and large industrial companies in our industry space. His skill set is uniquely suited for our organic and acquisitive strategic initiatives. Our customers, suppliers, employees and Board recognize his experience as providing a broad set of skills in his roles as our Chief Executive Officer and Board member. | |
13
PROPOSAL
Two:
TO FIX THE NUMBER OF DIRECTORS CONSTITUTING THE BOARD OF DIRECTORS AT
NINE
Article II, Section 1 of our Code of Regulations, which establishes the size of our Board, provides that the Board will consist of such number of directors, not less than three nor more than 12, as may be fixed from time to time by a majority vote of the shares which are represented at a meeting of shareholders. Currently, the size of the Board is fixed at ten directors.
The Board believes that it is in the best interest of the Company and its shareholders to decrease the size of the Board by one to nine members. Upon Mr. Hadeed’s retirement effective as of August 1, 2025, we will have nine directors continuing on the Board. Rather than fill the vacancy created by Mr. Hadeed’s retirement, the Board believes it is in the best interests of our shareholders to reduce the size of the Board and take the opportunity to reduce the compensation costs associated with Board membership. Our efforts in recent years to refresh the Board have provided us with a high level of diversity of experience and skills and sufficient members to continue satisfying the corporate governance requirements of the SEC and Nasdaq. The continuing directors and nominees are highly qualified individuals who can continue to contribute their knowledge, experience and expertise to Transcat.
We have not proposed a director nominee to fill the tenth Board seat at this year’s Annual Meeting. If this proposal is not approved by our shareholders, the size of our Board will remain at ten members and the tenth Board seat will be filled in the manner set forth in our Code of Regulations.
The affirmative vote of at least a majority of the shares of common stock which are represented at the meeting, in person or by proxy, is required to approve the proposal to fix the number of directors at nine. Abstentions and broker non-votes will count as votes against the proposal.
The Board recommends that you vote FOR the proposal to fix the number of directors at nine.
14
PROPOSAL
Three:
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF
OUR NAMED EXECUTIVE OFFICERS
Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), requires us to provide our shareholders with the opportunity to vote to approve, on an advisory basis, the compensation of our named executive officers (referred to as a “say-on-pay” vote). At our 2019 annual meeting of shareholders, we recommended and our shareholders approved, that we hold this non-binding, advisory vote on executive compensation on an annual basis. The Board subsequently adopted this preference and we are providing our shareholders with a say-on-pay vote this year. The next required vote on the frequency of the say-on-pay vote will occur at this Annual Meeting.
The primary goal of our compensation program is to align the interests of our named executive officers with those of our shareholders to achieve long-term growth. Our compensation philosophy is further described in the Compensation Discussion and Analysis (the “CD&A”) contained in this proxy statement. Shareholders are encouraged to read the CD&A which also discusses how our compensation programs implement our compensation philosophy and describes in detail our named executive officer compensation programs. The Compensation Committee and the Board believe the policies and procedures described in the CD&A are effective in implementing our compensation philosophy and in achieving our compensation goals and that the compensation of our named executive officers in fiscal 2025 reflects and supports these compensation policies and procedures.
We are asking our shareholders to indicate their support and approval for our named executive officer compensation as described in the CD&A. We believe that our compensation programs for our named executive officers are designed to create value for our shareholders over the long term and appropriately align pay with performance.
For the reasons summarized above and as discussed in more detail in the CD&A section of this proxy statement, the Board is asking our shareholders to vote for the following advisory resolution:
RESOLVED, that the shareholders approve the compensation of the Company’s named executive officers for fiscal 2025, as discussed and disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, the executive compensation tables and any related material disclosed in this proxy statement.
The say-on-pay vote is advisory and therefore it is not binding on our Compensation Committee or the Board. Nevertheless, the Board and our Compensation Committee value the opinions expressed by shareholders in their vote on this proposal and will consider the outcome of the vote in deciding whether to take any action as a result of the vote and when making future compensation decisions for our named executive officers.
The Board recommends that you vote FOR the proposal to approve, on an advisory basis, the compensation of our named executive officers.
15
PROPOSAL
Four:
ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE
COMPENSATION OF OUR NAMED EXECUTIVE
OFFICERS
As described in Proposal Three, our shareholders are being asked to vote to approve the compensation of our named executive officers as disclosed in the CD&A section of this proxy statement, including the accompanying compensation tables and the related narrative disclosure. As required by Section 14A of the Exchange Act, our shareholders are also entitled to vote on whether future advisory votes on named executive officer compensation should occur every year, every two years or every three years or to abstain from such voting. Shareholders will have an opportunity to cast an advisory vote on the frequency of future say-on-pay votes at least every six years. After the vote at this Annual Meeting, the next required vote on the frequency of the advisory vote on executive compensation will occur at our 2031 annual meeting of shareholders.
Our Board understands that there are different views as to what is an appropriate frequency for advisory votes on named executive officer compensation. After careful consideration, the Board is recommending that future say-on-pay votes occur every year, consistent with previous shareholder feedback. We believe that this frequency is appropriate because it provides shareholders with an opportunity to express their opinion annually as to named executive officer compensation, because compensation may change from year to year.
This advisory vote is non-binding on our Board and the Compensation Committee. However, the Board and the Compensation Committee will consider the voting results on this proposal in determining the frequency of future say-on-pay votes.
Shareholders can specify one of four choices when voting on this proposal: ONE YEAR, TWO YEARS, THREE YEARS or ABSTAIN. The outcome of this vote will be determined by a plurality of the votes cast. This means that the frequency that receives the most affirmative votes will be the frequency approved by our shareholders. Withheld votes, abstentions and broker non-votes will have no effect on the outcome of this matter.
The Board recommends that you vote for a “ONE YEAR” frequency for future advisory votes on the compensation of our named executive officers.
16
PROPOSAL
fIve:
RATIFICATION OF SELECTION OF
OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee has selected Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for the fiscal year ending March 28, 2026 (“fiscal 2026”). This selection is being presented to our shareholders for ratification at the Annual Meeting. The Audit Committee will consider the outcome of this vote in its future discussions regarding the selection of our independent registered public accounting firm.
We have been advised by Freed Maxick, P.C. (“Freed Maxick”), our independent registered public accounting firm for fiscal 2025, and Deloitte that a representative of each will be present at the Annual Meeting and will be available to respond to appropriate questions. We intend to give such representatives an opportunity to make a statement if they should so desire.
Recent Change in Auditor
As previously disclosed in the Form 8-K filed with the SEC on February 12, 2025, on February 6, 2025, the Company notified Freed Maxick of its dismissal as the Company's independent registered public accounting firm effective as of the date Freed Maxick completed its audit of the Company's consolidated financial statements for the fiscal year ended March 29, 2025. The decision to change the Company's independent registered public accounting firm was approved by the Audit Committee. On May 27, 2025, Freed Maxick completed its audit of the Company's consolidated financial statements as of and for the fiscal year ended March 29, 2025. Accordingly, the dismissal was effective May 27, 2025.
During the Company's fiscal years ended March 29, 2025 and March 30, 2024, and the subsequent interim period through the date of this proxy statement, there were no: (1) “disagreements” (within the meaning of Item 304(a)(1)(iv) of Regulation S-K and related instructions) with Freed Maxick on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to Freed Maxick’s satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement; or (2) “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K).
The audit reports of Freed Maxick on the consolidated financial statements of the Company as of and for the fiscal years ended March 29, 2025 and March 30, 2024, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. The audit reports of Freed Maxick on the effectiveness of internal control over financial reporting as of March 29, 2025 and March 30, 2024, did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles.
The Company provided Freed Maxick with a copy of the foregoing disclosure and requested that Freed Maxick furnish a letter addressed to the SEC stating whether Freed Maxick agrees with the above statements. A copy of the letter dated February 12, 2025 from Freed Maxick was filed as Exhibit 16.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 12, 2025.
As previously disclosed with the SEC on a Current Report on Form 8-K filed with the SEC on February 12, 2025, the Company engaged Deloitte as the Company’s independent registered public accounting firm for the fiscal year ending March 28, 2026, beginning with the review of the Company’s consolidated financial statements for the quarter ended June 28, 2025.
17
During the Company’s fiscal years ended March 29, 2025 and March 30, 2024, and the subsequent interim period through the date of this proxy statement, neither the Company nor anyone acting on its behalf consulted Deloitte with respect to either: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and no written report was provided to the Company or oral advice was provided that Deloitte concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a “disagreement” (as defined in Item 304(a)(1)(iv) of Regulation S-K and related instructions) or a “reportable event” (as described in Item 304(a)(1)(v) of Regulation S-K).
The Board recommends that you vote FOR the proposal to ratify the selection of Deloitte as our independent registered public accounting firm for the fiscal year ending March 28, 2026.
Fees for Professional Services Provided by Freed Maxick
The following table shows fees for professional services provided by Freed Maxick during fiscal 2025 and the fiscal year ended March 30, 2024 (“fiscal 2024”).
| Fiscal 2025 | Fiscal 2024 | |||||||
| Audit Fees | $563,725 | $499,897 | ||||||
| Audit-Related Fees | 158,658 | 46,000 | ||||||
| Tax Fees | — | — | ||||||
| All Other Fees | — | — | ||||||
| Total | $722,383 | $545,897 | ||||||
Audit fees during fiscal 2025 and fiscal 2024 were for professional services rendered for the audit of our annual consolidated financial statements, for the reviews of the financial statements included in our Quarterly Reports on Form 10-Q, for the audit of internal control over financial reporting and services typically provided by the accountant in connection with our regulatory filings. Audit-related fees for fiscal 2025 and fiscal 2024 included fees for work related to due diligence performed in the fiscal year.
Policy on Pre-Approval of Retention of Independent Registered Public Accounting Firm
In accordance with applicable laws, rules and regulations, the Audit Committee charter requires that the Audit Committee have the sole authority to review in advance and pre-approve all audit and non-audit fees and services provided to us by our independent registered public accounting firm. Accordingly, all audit services for which our independent registered public accounting firm was engaged are pre-approved by the Audit Committee. The Audit Committee may delegate to one or more designated members of the Audit Committee the authority to grant required pre-approval of audit and permitted non-audit services. The decision of any member to whom authority is delegated is required to be presented to the full Audit Committee at its next scheduled meeting.
Independence Analysis by the Audit Committee
The Audit Committee considered whether the provision of the services
described above was compatible with maintaining the independence of our independent registered public accounting firm and determined
that the provision of these services was compatible with the firm’s independence.
18
REPORT OF THE AUDIT COMMITTEE (1)
The Audit Committee of the Board is currently comprised of four members of the Board, each of whom the Board has determined is independent under the independence standards of the Nasdaq Stock Market and applicable SEC rules. The Audit Committee assists the Board in overseeing the Company’s accounting and financial reporting processes, financial statement audits and internal controls. The specific duties and responsibilities of the Audit Committee are set forth in the Audit Committee charter, which is available on our website, Transcat.com, under the heading “Investor Relations” and the subheading “Corporate Governance.”
The Audit Committee has:
| · | reviewed and discussed the Company’s audited consolidated financial statements for fiscal 2025 with management and Freed Maxick; |
| · | discussed with Freed Maxick the matters required to be discussed under auditing standards established from time to time by the Public Company Accounting Oversight Board and by SEC rules; |
| · | received and discussed the written disclosures and the letter from Freed Maxick required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence; and |
| · | discussed with Freed Maxick its independence. |
Based on these reviews and discussions with management and Freed Maxick and the report of Freed Maxick, and subject to the limitations on the committee’s role and responsibilities contained in the Audit Committee charter, the Audit Committee recommended to the Board, and the Board approved, that the audited consolidated financial statements for fiscal 2025 be included in the Company’s annual report on Form 10-K for fiscal 2025 for filing with the SEC.
The Audit Committee selects the Company’s independent registered public accounting firm annually and has submitted such selection for the fiscal year ending March 28, 2026 for ratification by shareholders at the Annual Meeting.
| Audit Committee: | |
| Oksana S. Dominach, Chair | |
| Charles P. Hadeed | |
| Cynthia M. Langston | |
| Robert L. Mecca | |
| (1) | The material in this report is not deemed to be “soliciting material,” or to be “filed” with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filings. |
19
CORPORATE GOVERNANCE
Board Meetings
The Board held 8 meetings during fiscal 2025. Each director then in office attended at least 75% of the total number of Board meetings and meetings of Board committees on which he or she served.
Director Independence
The Board has determined that each of Mses. DePerrior, Dominach and Langston and Messrs. Cairns, Gillette, Hadeed, Haseley, Kaniki, and Mecca are independent under the independence standards of the Nasdaq Stock Market. Each member of our Audit Committee, Compensation Committee and NESG Committee is “independent” as defined in the currently applicable Nasdaq Stock Market listing standards, and each member of our Audit Committee and Compensation Committee also meets the heightened standards of “independence” under the Nasdaq Stock Market listing standards for Audit Committee and Compensation Committee members, as applicable.
Executive Sessions
During fiscal 2025, our independent directors met in regularly scheduled executive sessions without management present, as required by the listing standards of the Nasdaq Stock Market. The Chairman of the Board presided over the executive sessions of the independent directors.
Board Leadership Structure
The Board separates the roles of Chief Executive Officer and Chairman of the Board based on the Board’s belief that corporate governance of the Company is most effective when these positions are not held by the same person. The Board recognizes the differences between the two roles and believes that separating them allows each person to focus on his individual responsibilities. Under this leadership structure, our Chief Executive Officer can focus attention on day-to-day company operations and performance, and can establish and implement long-term strategic plans, while our Chairman can focus attention on Board responsibilities. Additionally, the Board recognizes its obligations to confer in executive session with its independent directors.
Presently, the Board believes it is appropriate to keep the roles of Chief Executive Officer and Chairman of the Board separate. The Board may, however, change the leadership structure if it believes that a change would better serve the Company and its shareholders.
Under our Corporate Governance Guidelines, if the same person serves as Chairman of the Board and Chief Executive Officer, a majority of our non-employee directors will select an independent director to serve as a Lead Independent Director under a Lead Independent Director Charter. If required, the Lead Independent Director would be responsible for conducting regularly scheduled executive sessions of the non-management or independent directors and such other responsibilities as set forth in the Lead Independent Director Charter or as the independent directors may assign.
Retirement Policy and Mandatory Resignation
The mandatory retirement age for Board members is age 75. However, the Board has reserved the right to extend the mandatory retirement age if it will better serve the interests of our shareholders and the Company. If a director will turn 75 during an elected term, the NESG Committee will not recommend that director for re-election unless the committee believes it is in the best interest of the Company for that director to continue to serve on the Board for another term.
20
As part of our Corporate Governance Guidelines, we have a mandatory resignation policy for directors in the event civil or criminal charges are brought against the director or if a director becomes infirmed.
Service on Other Public Company Boards
As part of our Corporate Governance Guidelines, our directors should not serve on more than three other public company boards of directors in addition to our Board and our CEO should not serve on more than one other public company board of directors unless approved by the NESG Committee.
Board Committees
The Board has standing Audit, Compensation, Executive, NESG, and Technology Committees. The table below shows the number of meetings held during fiscal 2025 and the names of the directors currently serving on each committee.
| Committee Name |
Number of Meetings Held During Fiscal 2025 |
Committee Members | |||
| Audit | 5 |
Ms. Dominach (1) Ms. Langston |
Mr. Hadeed Mr. Mecca | ||
| Compensation | 5 |
Mr. Cairns (1) Ms. Dominach |
Ms. DePerrior Mr. Kaniki | ||
| Executive | 4 |
Mr. Haseley (1) Mr. Hadeed Mr. Rudow |
Ms. Dominach Mr. Kaniki | ||
| NESG | 4 |
Mr. Kaniki (1) Ms. Langston |
Mr. Gillette | ||
| Technology | 3 |
Ms. Langston (1) Mr. Gillette |
Ms. DePerrior | ||
| (1) Chair | |||||
Each committee acts pursuant to a written charter adopted by the Board. The current charter for each committee is available on our website, Transcat.com, under the heading “Investor Relations” and the subheading “Corporate Governance.”
Audit Committee
The Board has determined that each member of the Audit Committee has sufficient knowledge in financial and auditing matters to serve on the committee and is independent under applicable Nasdaq Stock Market and SEC rules. The Board has designated Ms. Dominach as an “audit committee financial expert” in accordance with applicable SEC rules based on her professional experience as described in her biography under “Proposal One: Election of Directors.”
The Audit Committee serves as an independent and objective party to monitor our financial reporting process and internal control system; retains, pre-approves audit and permitted non-audit services to be performed by, and directly consults with, our independent registered public accounting firm; reviews and appraises the services of our independent registered public accounting firm; provides an open avenue of communication among our independent registered public accounting firm, financial and senior management, and the Board; and assists the Board in risk oversight of the Company. Our Audit Committee charter more specifically sets forth the duties and responsibilities of the Audit Committee.
21
The Audit Committee, which was established in accordance with Section 3(a)(58)(A) of the Exchange Act, is also responsible for preparing the Audit Committee’s report that SEC rules require be included in this proxy statement and for performing such other tasks that are consistent with its charter. The Audit Committee’s report relating to fiscal 2025 appears under the heading “Report of the Audit Committee.”
Compensation Committee
The Compensation Committee is responsible for establishing and implementing compensation programs for our executive officers and directors that further the intent and purpose of our fundamental compensation philosophy and objectives and for performing such other tasks that are consistent with its charter.
For more information on executive compensation and director compensation and the role of the Compensation Committee, see the “Compensation Discussion and Analysis” and “Director Compensation” sections of this proxy statement.
Executive Committee
The Executive Committee acts on behalf of the Board between regularly scheduled Board meetings and subject to certain limitations imposed by applicable legal or regulatory requirements. Subject to limitations, the Executive Committee is delegated and may exercise all authority of the Board between meetings, other than (i) the filling of vacancies on the Board; and (ii) those matters that are specifically delegated to other Board committees or are under active review by the Board or a Board committee, unless the Board specifically determines otherwise. The Executive Committee may also be delegated specific actions and authority from time to time by the Board.
NESG Committee
The NESG Committee is charged with identifying candidates, consistent with criteria approved by the NESG Committee, qualified to become directors and recommending that the Board nominate such qualified candidates for election as directors. The NESG Committee is also responsible for reviewing our Code of Regulations and Corporate Governance Guidelines, shaping corporate governance, overseeing the evaluation of the Board, the Board committees and management, and performing such tasks that are consistent with the NESG Committee charter. In addition, the NESG Committee reviews, evaluates and recommends implementation of or changes to our corporate environmental, social and governance policies.
The process the NESG Committee follows to identify and evaluate candidates includes requests to Board members, the Chief Executive Officer and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to potential candidates and their qualifications, and interviews of selected candidates.
The NESG Committee also considers and establishes procedures for shareholder recommendations of nominees to the Board. Shareholder recommendations, together with relevant biographical information, should be sent to the following address: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary. The qualifications of recommended candidates will be reviewed by the NESG Committee.
In evaluating the suitability of candidates (other than our executive officers) to serve on the Board, including candidates recommended by shareholders, the NESG Committee seeks candidates who are independent under the independence standards of the Nasdaq Stock Market and meet certain selection criteria established by the committee from time to time. The NESG Committee also considers an individual’s skills, character and professional ethics, judgment, leadership experience, business experience and acumen, familiarity with relevant industry issues, national and international experience, and other relevant criteria that may contribute to our success. The NESG Committee evaluates candidates in light of their skill sets
22
and other characteristics that complement those of the current Board, including the diversity, skills and experience of the Board as a whole. Although the NESG Committee does not have a specific written diversity policy, the committee values and considers diversity, including with respect to skills and experience, when seeking and evaluating candidates for the Board.
Technology Committee
The Technology Committee assists the Board in fulfilling its corporate governance and oversight responsibilities for the Company’s operations and technology and information systems (“IT”) strategy. The Technology Committee is primarily responsible for making recommendations to the Board related to our IT policy and procedures, including IT strategies, technology investments, and oversight of IT management within the Company. The Technology Committee receives detailed reports from our Chief Information Officer about cybersecurity risk management and the technologies, policies, processes and practices for managing and mitigating cybersecurity risks and the Company’s cyber-attack incident response and recovery plan in order to assist the Audit Committee with its risk oversight responsibilities. Our Technology Committee charter more specifically sets forth the duties and responsibilities of the Technology Committee.
Director Attendance at Annual Meetings
Company policy outlined in our Corporate Governance Guidelines requires all directors, absent special circumstances, to attend our annual shareholder meetings. All but two of our directors attended the annual meeting of shareholders held on September 11, 2024.
The Board’s Role in Risk Oversight
The Board is responsible for overseeing risks that could affect the Company. This oversight is conducted primarily through the Board’s committees. The Audit Committee assists the Board in risk oversight in coordination with the other committees of the Board as appropriate reviewing with management, at least annually, the Company’s (i) major financial risk and enterprise exposures; (ii) major legal and regulatory compliance risk exposures; and (iii) major cybersecurity and IT risk exposures, and for each, the steps management has taken to monitor or mitigate such exposures. The Audit Committee also periodically reviews with management the Company’s major risk exposures in other areas, as the Audit Committee deems necessary or appropriate. The Compensation Committee focuses on the management of risks arising from our compensation policies and programs. The NESG Committee focuses on the management of risks associated with Board organization, membership, and structure, as well as major environmental, social and governance risk exposures. The Technology Committee receives detailed reports from our Chief Information Officer about cybersecurity risk management to assist the Audit Committee with its management of cybersecurity and IT risks.
While the Board committees are focused on these specific areas of risk, the full Board retains responsibility for general risk oversight. The Board satisfies this responsibility by reviewing periodic reports from each committee chair regarding the risk considerations within each committee’s area of expertise, as well as periodic reports to the Board or the appropriate committee from the members of our senior management team who are responsible for risk management.
As part of its risk oversight responsibilities, the Board and its committees review the processes that senior management use to manage risk exposure. In doing so, the Board and its committees review our overall risk function and senior management’s establishment of appropriate systems and processes for managing areas of material risk to the Company, including, but not limited to, operational, financial, legal, regulatory, strategic, and IT risks.
23
Code of Business Conduct and Ethics
We have a Code of Business Conduct and Ethics that applies to all of our directors, officers and employees, including our principal executive officer, principal financial officer, and principal accounting officer and controller. You can find our code of business conduct and ethics on our website, Transcat.com, under the heading “Investor Relations” and the subheading “Corporate Governance.”
We intend to post any amendments to or waivers from our Code of Business Conduct and Ethics applicable to our principal executive officer, principal financial officer, and principal accounting officer and controller or persons performing similar functions on our website. The information contained on our website is not a part of this proxy statement.
Insider Trading Policy
We have an
Shareholder Communications
Shareholders may send correspondence by mail to the full Board or to individual directors. Shareholders should address correspondence to the Board or individual directors in care of: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary.
All shareholder correspondence will be compiled by our Corporate Secretary and forwarded as appropriate. In general, correspondence relating to corporate governance issues, long-term corporate strategy, or similar substantive matters will be forwarded to the Board, the individual director, one of the aforementioned committees of the Board, or a committee member for review. Correspondence relating to ordinary business affairs or those matters more appropriately addressed by our officers or their designees will be forwarded to such persons accordingly.
Environmental and Social Responsibility
Our business requires that we uphold high standards and trust in the integrity of our people and processes, and our policies support our commitment to conducting our business in a socially and environmentally responsible way. We strive to perform to the highest level of integrity and ethics at all times. This expectation flows down to our suppliers who are expected to comply with our Supplier Code of Conduct.
We are committed to promoting social responsibility and human rights across our operations. Accordingly, we adopted a Global Human Rights Policy and Statement on Modern Slavery and Human Trafficking, with which we expect our employees, supply chain partners and other business partners to comply.
We are committed to good corporate citizenship within the communities and countries in which we operate and will work to develop good relationships within, and positively impact, these communities. To that end, in addition to our Global Human Rights Policy, we also adopted a Global Policy on Conflict Minerals which is intended to support our commitment to global efforts to end human rights abuses associated with continuing violent conflicts that may be funded through the sale of certain minerals.
24
Our Global Environmental Policy reflects our commitment to community and to conducting business in an environmentally responsible manner that protects our natural resources and the environment and is in material compliance with all applicable environmental, health and safety obligations.
All of our policies pertaining to our Environmental, Social and Supplier responsibilities are available on our website.
Our Board is actively involved in fostering a worldwide, regional and local view as we continue to implement programs and policies that reflect the needs of the communities in which we operate.
Community Engagement
With 33 laboratories in North America and Ireland, we are committed to making a positive impact in those communities. In 2023, we introduced a Community Engagement program which identifies an area of societal need to receive donated funds. Our Community Engagement program provides an opportunity for employees to participate in paid volunteer work to assist in those identified areas, as appropriate.
Community Crisis Support
We strive to be a positive contributor to every community in which we are located. When one of our communities is in crisis, we want to help. Our Community Crisis Support fund is designated to assist communities during the aftermath of natural disasters such as hurricane relief and other events that may create a need for support.
Employees
With our international presence, we strive to maintain an inclusive work environment everywhere along with recognizing and respecting our employees’ backgrounds and experiences. We recruit the best people for the job without regard to race, ethnicity, gender, sexual orientation or any other protected status. It is our policy to comply fully with all domestic, foreign and local non-discrimination employment laws.
Our principles are reflected in our employee training, in particular with respect to our policies against harassment and bullying and the elimination of bias in the workplace. In addition, to support our employees’ mental health and emotional well-being, all employees and their dependents worldwide have access to an Employee Assistance Program at no cost to them. This includes access to visits with mental health care providers.
Scholarship Program
Transcat has created employment and educational opportunities in the communities where we are located in the form of a scholarship that provides an award to be used towards the recipient's higher education tuition and an eight-week paid summer position as a Technician Trainee. This scholarship is awarded to at least two individuals based on their academic records, accomplishments, professional goals, and other factors that indicate promise for a successful career in the calibration industry.
Workforce Development and Wellness
We provide workforce development, education and training that has built a strong talent pipeline.
Transcat’s Calibrated Wellness Program prioritizes our employees’ well-being and is designed to enhance their health. Our program includes wellness resources, health education, pharmaceutical cost guidance, and a no-cost Employee Assistance Program, which includes worldwide access to visits with mental health care providers. Our program also incentivizes health and well-being by providing reduced health insurance premiums for employees who complete certain actions that encourage health and wellness.
25
Transcat U
Our people are one of our most valuable investments. To that end, we are leading the way in the calibration industry by investing in training calibration technicians and building supportive career paths with Transcat U. Founded in 2021, Transcat U is a technician training program for external and internal candidates that provides support for new technician trainees who often have little to no previous experience in metrology.
Humane Workplace
Our employees are all voluntary labor, and we oppose any and all forms of modern slavery and do not engage or use any labor that is sourced from human trafficking. In complying with international labor standards, we do not employ child labor. Our full statement against the use of slavery and human trafficking can be found in our Modern Slavery and Human Trafficking Policy on our website.
Workforce
We recruit and hire the most qualified people for our open positions without regard to protected status (age, color, creed, disability, domestic violence victim status, gender identity, genetic predisposition or carrier status, marital status, national origin, pregnancy, race, religion, sex, sexual orientation, status as a protected veteran or as a member of any other protected group or activity). Any form of violence, harassment, and bullying in the workplace is prohibited and we protect our employees from any retaliation for complaining about or participating in an investigation of workplace conditions.
Privacy
We believe that privacy is a fundamental human right and a responsibility that we have to our trusted stakeholders, customers and employees. Our privacy policy can be found on our website.
Wages and Benefits
Our compensation and benefits program is designed to attract and reward individuals who demonstrate the ability and desire to enhance our workplace culture, support our values, drive our operational and strategic goals, and create long-term value for our shareholders. We provide employees with competitive compensation packages that include base salary and may also include annual incentive bonuses and/or long-term incentive awards, depending upon the employee’s position. We believe that a compensation program with both short-term and long-term incentive awards provides fair and competitive compensation and aligns employee and shareholder interests. In addition to cash and equity compensation, we also offer employees myriad benefits, including health (medical, dental and vision), life, and disability insurance, paid time off, paid parental leave, tuition benefits, and a 401(k) plan.
Health and Safety
The health and safety of our employees is of utmost importance to us. We have enhanced our Safety Program with additional training and internal risk and hazard assessments. Our annual policy reviews ensure compliance with health and safety guidelines and regulatory requirements. Our employees are provided all necessary personal protective equipment as required by applicable standards and as appropriate.
We have a dedicated resource and full-time employee that is focused on enhancing our health and safety program which includes annual internal safety assessments. Our goal is to achieve a level of work-related injuries as close to zero as possible through continuous investment in our safety program.
26
EXECUTIVE OFFICERS AND SENIOR MANAGEMENT
We are served by our executive officers, Messrs. Rudow, Barbato, Haddad, and West and Ms. Conroy, together with four additional members of the senior management team.
Thomas L. Barbato, age 55, is our Chief Financial Officer and Treasurer having served us in this position since August 2022. Mr. Barbato previously served as our Senior Vice President, Finance since January 2022. Mr. Barbato served as the Chief Financial Officer of IEC Electronics Corp., a provider of manufacturing services for advanced technology companies and formerly a public company until it merged with Creation Technologies Inc. in October 2021, from September 2018 to December 2021. Mr. Barbato held various positions with Xerox Corporation from 1995 until 2018, most recently as Vice President of Finance, North American Operations, Pricing and Contracting Center of Excellence from January 2017 to September 2018.
Marcy R. Bosley, age 47, has served as our Vice President of Sales since July 2020, having previously served as a Senior Director of Sales for us from February 2019 until such time. Ms. Bosley has 19 years of experience in the calibration industry. Prior to joining us, Ms. Bosley served in various roles for SIMCO Electronics, a leading provider of calibration and software services for test and measurement instruments used in technology organizations, from 2009 until February 2019, most recently as Vice President, Sales from September 2018 to February 2019, and head of North American area sales from July 2016 to September 2018.
Theresa A. Conroy, age 61, is our Senior Vice President of Human Resources and has served us in this position since May 2023, after joining us in January 2022 as Vice President of Human Resources. Previously, Ms. Conroy was a partner at Harter Secrest & Emery LLP from 2003 until December 2021 where her practice focused on labor, employment, human resources and higher education law.
Scott D. Deverell, age 60, joined us in February 2016 and will serve as our Corporate Controller and Principal Accounting Officer until his retirement in fiscal 2026. Prior to joining us, Mr. Deverell served as Vice President of Finance and Administration for Sydor Instruments, a comprehensive diagnostics solution provider, which he joined in April 2015. From 2009 to 2014, Mr. Deverell served as Division President for Stewart Title Insurance Company, a title insurance underwriter.
Randy Ford, age 50, has served as our Vice President of Operations since April 2023, having previously served as our Senior Director of Metrology and Operations from August 2021 until such time. Prior to joining us, Mr. Ford served in various roles for SIMCO Electronics, a leading provider of calibration and software services for test and measurement instruments, from 2007 to August 2021. Most recently he served as Director of Quality, Operational Excellence and IT/IS from March 2016 until August 2021, and Southwest Area Director from February 2015 to March 2016. Mr. Ford has over 29 years of experience in the calibration industry.
Michael J. Haddad, age 45, has served as our Chief Information Officer since September 2024. From April 2019 to September 2024, Mr. Haddad served as the General Manager of US Payer and Provider Business Segments of IQVIA, a global provider of data, analytics, technology solutions and clinical research services. Mr. Haddad served as an independent consultant advising executives in healthcare and IT professional services industries from June 2017 to April 2019. From May 2011 to January 2016, Mr. Haddad served as a senior IT leader for Blue Cross Blue Shield of Michigan before serving as the Chief Information Security Officer of Advantasure, a former subsidiary of Blue Cross Blue Shield of Michigan, from April 2016 to May 2017. Mr. Haddad began his career at Deloitte, having served as a Senior Manager with expertise in Sarbanes-Oxley compliance, enterprise application integrity, identity & access management, and data loss prevention. Mr. Haddad also currently serves as a member of the CNBC
27
Technology Executive Council, a council of technology executives that leads discussions about employing breakthrough technologies to solve problems and power growth while addressing the challenges presented by those innovations.
Lee D. Rudow, age 61, is our President and Chief Executive Officer. Additional information about Mr. Rudow can be found under “Proposal One: Election of Directors.”
D. Scott Smith, age 49, has served as our Vice President of Operations since April 2023. Mr. Smith joined us in 2005 and most recently served in the position of Senior Director of Acquisitions and Integrations since March 2021. From January 2005 through September 2017, he held various finance positions including Senior Director of FP&A and from October 2017 to February 2021 was our Senior Director of Operations Performance and Integrations.
Michael W. West, age 54, has served as our Chief Operating Officer since April 2024. He most recently served as our Senior Vice President of Business Operations since April 2023 and prior to that as our Vice President of Distribution and Marketing since November 2014. From 1995 to 2014, Mr. West was a principal owner of QuestCom Inc., a marketing and advertising company, and served most recently as a marketing consultant to various direct mail, web and catalog clients. Mr. West worked with our marketing team, as one of his clients, for 13 years.
28
COMPENSATION DISCUSSION AND ANALYSIS
Named Executive Officers
Our CD&A describes the material elements of our executive compensation program and decisions in fiscal 2025 for our named executive officers (the “NEOs”), who for fiscal 2025 were:
| · | Lee D. Rudow, President and Chief Executive Officer; |
| · | Thomas L. Barbato, Chief Financial Officer and Treasurer; |
| · | Theresa A. Conroy, Senior Vice President, Human Resources; |
| · | Michael J. Haddad, Chief Information Officer; and |
| · | Michael W. West, Chief Operating Officer. |
Fiscal 2025 Business Results
| · | Total revenue was $278 million in fiscal 2025, an increase of $18.9 million or 7.3% from fiscal 2024. |
| · | Service segment revenue was $181 million, an increase of 7.0% from the prior fiscal year. |
| · | Consolidated gross profit was $89.5 million in fiscal 2025, up $5.6 million, or 6.7% from fiscal 2024 and gross margin was 32.1% in fiscal 2025, a decrease of 20 basis points from fiscal 2024. |
| · | Net income was $14.5 million in fiscal 2025, a $0.8 million increase from fiscal 2024 and net income per diluted share was $1.57, down from $1.63 in fiscal 2024. |
| · | Adjusted EBITDA* was $39.7 million in fiscal 2025, which represented an increase of $1.1 million or 2.9% from fiscal 2024. |
* Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure.
Determining NEO Compensation
Philosophy and Objectives
Our compensation program is designed to attract, motivate and retain a highly-qualified and effective executive management team. We believe that the most effective executive compensation program is one that is designed to reward the achievement of specific annual, long-term and strategic company goals, which align the interests of each of our executive management team with those of our shareholders.
The objectives of the compensation program for our NEOs are to motivate them to achieve our business objectives, to reward them for achievement, to foster teamwork, to support our core values and to contribute to our long-term success. Our compensation policies for our NEOs are designed to link pay to both performance, taking into account the level of difficulty associated with each executive’s responsibilities, and shareholder returns over the long term. We believe the compensation provided to our NEOs is competitive with the compensation paid to executives with similar responsibilities in comparable companies, and the Compensation Committee is focused on better aligning our NEOs’ compensation with our peer group, as described further below.
Role of the Compensation Committee
The Compensation Committee is responsible for establishing, implementing and monitoring adherence to our compensation philosophy and objectives. The Compensation Committee reviews, recommends and approves salaries and other compensation of our Chief Executive Officer and other executive officers, administers our cash and equity incentive plans (including reviewing and approving awards to executive
29
officers), approves all benefit plans and programs including bonus and retirement plans, policies and programs, and makes recommendations to the Board with respect to the compensation of directors. The Compensation Committee’s policy is to provide a competitive total compensation package to our NEOs. Generally, the types of compensation and benefits provided to our NEOs are similar to those provided to our other executive management team members. The Compensation Committee is also responsible for reviewing the CD&A and for preparing the Compensation Committee Report included in this proxy statement.
Our Compensation Committee and our Board, as applicable, do not assign relative weights or rankings to factors, and do not consider any single factor as determinative in the compensation of our NEOs. Rather, our Compensation Committee and our Board, as applicable, rely on their own knowledge and judgment in assessing performance and making compensation decisions.
Role of Management
Upon completion of the fiscal year, our Chief Executive Officer and our Chief Financial Officer review our performance against each pre-established corporate financial objective, comparing the fiscal year results to the pre-determined threshold, target and maximum levels for each objective, and an overall percentage for the corporate financial objectives is calculated. The results of our financial performance are then reviewed and approved by the Compensation Committee and the Board.
With respect to an individual’s performance portion of the annual performance-based cash incentive award, our Chief Executive Officer evaluates each officer’s accomplishments (other than the Chief Executive Officer’s himself) relative to their individual objectives and calculates a performance rating based on the performance-based cash incentive plan previously approved by the Compensation Committee. Individual performance goals for our NEOs are carefully designed to create alignment between our short and long-term objectives and strategies, and the individual’s performance.
Role of Compensation Consultant
Under its charter, our Compensation Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other advisor. In fiscal 2025, the Compensation Committee engaged Frederic W. Cook & Company, Inc. (“FW Cook”), as its independent compensation consultant, to provide advice regarding peer group companies and to assist with the determination of NEO compensation. The Committee assessed the independence of FW Cook pursuant to SEC rules and concluded their work did not raise any conflicts of interest.
Competitive Market Data
The Compensation Committee reviews market data on executive pay levels and program design to assist in determining appropriate compensation for the NEOs. For fiscal 2025, the Compensation Committee did not benchmark compensation to a particular percentile of market data, but rather used market data as context when establishing compensation.
In fiscal 2023, we engaged FW Cook to provide a competitive frame of reference for compensation decisions, which included the recommendation of a new peer group. Our peer group consists of selected companies drawn from a broad group of public companies from similar industries and comparable size. FW Cook noted (as our Compensation Committee has noted in prior years) that we have no pure peers. We used the peer group to inform the Compensation Committee’s determinations for fiscal 2025 compensation. Our peer group consists of the following public companies:
30
| AeroVironment, Inc. | Argan, Inc. | CIRCOR International, Inc. |
| Cryoport, Inc. | Cutera, Inc. | Ducommun Incorporated |
| Enzo Biochem, Inc. | Harvard Bioscience, Inc. | InfuSystem Holdings, Inc. |
| Inogen, Inc. | Kaman Corporation | LeMaitre Vascular, Inc. |
| Ligand Pharmaceuticals Incorporated | Mesa Laboratories, Inc. | Powell Industries, Inc. |
| Standex International Corporation | Surmodics, Inc. | Twin Disc, Incorporated |
| Willis Lease Finance Corporation |
The Compensation Committee determined in 2023 that market data warranted certain out of step increases for our Chief Executive Officer and NEOs during fiscal 2023 and fiscal 2024. After consulting with FW Cook, the Compensation Committee determined to continue these out of step increases of increased base compensation, bonus percentages, and long-term equity for our Chief Executive Officer and Senior Vice President, Human Resources during fiscal 2025. The compensation of our Chief Operating Officer increased in connection with his promotion in April 2024, better aligning his compensation with the median of our peer group. The Compensation Committee did not award any out of step time-based or performance-based equity to our NEOs in fiscal 2025 except for a one-time long-term award to our Chief Operating Officer in connection with his promotion. Future realignment of compensation with our peer group may continue (if warranted) in fiscal 2026.
Say-on-Pay
Our shareholders will have an opportunity to cast an advisory vote on the compensation of our NEOs, commonly referred to as the “say on pay” vote, at the Annual Meeting. At our 2024 annual meeting of shareholders, we held an advisory vote on the compensation of our NEOs which resulted in 97% of the votes cast approving our compensation program for our NEOs. We evaluated the results of this vote as part of our overall assessment of our compensation program for our NEOs. Based on this overall assessment and the support expressed by our shareholders, we did not make any related material changes to our compensation program for our NEOs.
At our 2019 annual meeting of shareholders, we recommended, and our shareholders approved, an annual frequency for the say-on-pay vote. After considering that recommendation, the Board determined that the say-on-pay vote will be held annually until the next required vote on the frequency of the say-on-pay vote, which is being held at this Annual Meeting.
Risk and Compensation Policies
In considering the risks to us and our business that may be implied by our compensation plans and programs, our Compensation Committee considers the design, operation and mix of the plans and programs at all levels. Our compensation program is designed to mitigate the potential to reward excessive risk-taking that may produce short-term results that appear in isolation to be favorable, but that may undermine the successful execution of our long-term business strategy and erode shareholder value. The Compensation Committee has reviewed our compensation policies as generally applicable to our employees and believes that our policies do not encourage excessive and unnecessary risk-taking, and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on us.
Clawback Policy
We have a Policy on Recoupment of Incentive Compensation (the “clawback policy”) which allows us to (i) recover erroneously awarded incentive-based compensation received by our current and former
31
executive officers if we are required to prepare a restatement of our financial statements due to material noncompliance with any financial reporting requirement under federal securities law, and (ii) recover any awards (which include both performance-vesting and time-vesting options, restricted stock, restricted stock units and annual and long-term incentives and cash bonuses) granted or paid to our current and former employees if they engage in detrimental conduct. We believe the clawback policy will maintain and enhance a culture that is focused on integrity and accountability, and that seeks to discourage conduct detrimental to our long-term growth.
Stock Option Grant Timing Policy
Anti-Hedging Policy
We have an anti-hedging policy that prohibits directors, officers and employees from engaging in transactions that hedge or offset any decrease in the market value of equity securities granted as compensation.
Tax Considerations
Tax rules generally limit the deductibility of compensation paid to each of our NEOs and certain former NEOs to $1 million per year. The Compensation Committee retains the discretion to pay compensation that may not be tax deductible.
Stock Ownership Objectives
To more closely align the efforts of our NEOs with the interests of our shareholders, we set a minimum stock ownership objective for our NEOs. This objective encourages our NEOs to work towards acquiring and maintaining specific levels of equity ownership in our common stock. Under these objectives, our NEOs are expected to achieve their respective ownership objectives within five years of becoming an NEO. The Compensation Committee and the Chief Executive Officer monitor the progress toward achievement of stock ownership objectives and, if warranted, can make reductions in long-term compensation awards as deemed appropriate.
Mr. Rudow’s stock ownership objective is 2.5 times his base salary rate. The stock ownership objective for each of Ms. Conroy and Messrs. Barbato, Haddad and West is 1.5 times their base salary rate. Unvested restricted stock units count towards achieving this objective. At the end of fiscal 2025, all NEOs were in compliance with the terms of our stock ownership objective.
32
Elements of Executive Compensation
Overview of Compensation Components
We seek to achieve the objectives for our executive compensation program through the following compensation elements.
| Compensation Element | Key Characteristics | Link to Objectives | ||
| Base salary | Fixed; reviewed annually | To provide a competitive rate of pay | ||
| Annual performance-based cash incentive compensation | Variable; based on Company performance (CEO) and individual and Company performance (NEOs other than the CEO) | To ensure that a portion of compensation is at risk and linked to Company performance (CEO) and individual and Company performance (NEOs other than the CEO) | ||
| Long-term incentive awards | Variable; granted half in time-based awards and half in Company performance-based awards | To reinforce the NEO’s long-term commitment to the Company’s success and, with respect to the performance-based awards, to align with shareholder interests | ||
| Benefits and perquisites | Fixed; substantially the same as the benefits offered to other employees of the Company, including vacation, sick time, participation in a 401(k) plan and health and welfare plans | To provide competitive levels of benefits that promote health, wellness and financial security |
In addition to the elements described in the table above, other equity-based awards may also be awarded to our NEOs in unique circumstances. A significant percentage of total compensation for our NEOs is placed at risk through annual and long-term incentives. There are established guidelines and targets regarding the allocation between annual (short-term) and long-term incentive compensation which is contingent and variable, based on Company results and individual performance.
Pay Mix
Our annual executive compensation program includes fixed components (base salary, benefits and perquisites) and variable components (annual performance-based cash incentive compensation and long-term equity incentive awards), with the heaviest weight generally placed on the variable, or “at risk,” components. For fiscal 2025, a majority of our Chief Executive Officer’s and our other NEOs’ target annual
33
compensation was weighted toward at-risk compensation, as shown by the following graphs.
Base Salary
The Compensation Committee reviews base salaries for each of our NEOs at least annually. Base salary rate increases are made as necessary based on performance, scope of responsibilities and market information. During fiscal 2025, the Compensation Committee approved an increase in the base salary rate for our Chief Executive Officer, Chief Financial Officer, Senior Vice President, Human Resources and Chief Operating Officer to better align with peer pay levels.
| Name | Fiscal 2025 Base Salary Rate | Fiscal 2024 Base Salary Rate | ||
| Lee D. Rudow | $649,600 | $617,210 | ||
| Thomas L. Barbato | $381,000 | $327,330 | ||
| Theresa A. Conroy | $299,000 | $234,920 | ||
| Michael J. Haddad | $300,000 | — | ||
| Michael W. West | $350,000 | $260,164 |
Annual Performance-Based Cash Incentive Compensation
We maintain an annual performance-based cash incentive plan, which is designed to compensate key management members, including our NEOs. Payment of performance-based cash incentive awards under the annual performance-based cash incentive plan for our Chief Executive Officer is expressly linked to successful achievement of specific pre-determined corporate goals, which our Board approves on an annual basis. Payment of performance-based cash incentive awards for our other NEOs is typically based on successful achievement of the same specific pre-established corporate goals, as well as individual performance goals which are determined by our Chief Executive Officer. The performance-based cash incentive plan includes various incentive levels based on a participant’s position within the Company, accountability, and impact on our operations. Target award opportunities are established as a percentage of base salary. The target award opportunity under the performance-based cash incentive plan for fiscal 2025
34
as a percentage of base salary for each of our NEOs is set forth in the following table.
| Name |
Fiscal 2025 Target Percentage of Base Salary | |
| Lee D. Rudow | 85% | |
| Thomas L. Barbato | 50% | |
| Theresa A. Conroy | 40% | |
| Michael J. Haddad | 40% | |
| Michael W. West | 40% |
Company performance against the objectives results in a corporate payout factor used to establish the aggregate pool available for incentive awards. Individual awards were determined by using a multiplier to adjust annual incentive payouts for achievement of individual performance objectives (for NEOs other than our Chief Executive Officer) and subjecting such adjustments to the aggregate incentive pool, subject to a cap on individual awards.
In addition to the performance goals, the annual performance-based cash incentive plan also provides guidelines for the calculation of annual incentive-based compensation, subject to Compensation Committee oversight and modification. The Compensation Committee established a threshold, target and maximum objective for each financial performance metric, with the corresponding corporate payout factor, as follows:
| Achievement | Percent of Annual Operating Plan | Corporate Payout Factor | ||
| Maximum | 115% | 200% | ||
| Target | 100% | 100% | ||
| Threshold | 90% | 33% |
Performance against each financial performance metric is measured separately. If actual results fall below the threshold objective, the corporate payout factor will be 0%. If actual results fall in between the designated levels of achievement, the corporate payout factor will be interpolated. Generally, if actual results exceed the maximum objective, the corporate payout factor will be limited to 200% of target.
NEOs with individual performance objectives must achieve at least a minimum performance level (a rating of 1 on a scale of 0 to 5) against such individual performance objectives to be eligible for any portion of the performance-based cash incentive award. In general, a participant must be an employee on or before December 1st of the plan year and on the last day of the fiscal year to be eligible for an award. However, if a participant’s employment terminates due to death or disability prior to the end of the plan year, the participant’s final award will be based on the Company and individual’s performance against objectives multiplied by their earnings through the date of termination.
For fiscal 2025, the corporate objectives, relative weights, and levels of performance achieved were as follows:
| Corporate Objective | Weight | Fiscal 2025 Level of Performance | ||
| Adjusted EBITDA(1) | 40% | 78% | ||
| Service segment gross profit | 40% | 90% | ||
| Board’s assessment of corporate performance | 20% | 100% |
| (1) | Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure. |
Following the Compensation Committee’s review of the achievement of corporate financial objectives and
35
individual performance objectives for fiscal 2025, the Compensation Committee awarded the following amounts of performance-based cash incentive compensation to each of our NEOs:
| Name | Fiscal 2025 Performance-Based Cash Incentive Award | |
| Lee D. Rudow | $194,968 | |
| Thomas L. Barbato | $67,266 | |
| Theresa A. Conroy | $42,231 | |
| Michael J. Haddad | $21,186 | |
| Michael W. West | $49,434 |
Long-Term Equity Incentive Awards
We grant long-term equity incentive awards in the form of time-based restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”) as a component of executive compensation to reinforce our NEOs’ long-term commitment to our success and, with respect to the PSUs, to align with shareholder interests. Our Compensation Committee sets target equity award levels as a percentage of annualized base salary based on our NEOs’ positions within the Company. Long-term performance-based incentive compensation is targeted to a specific dollar award, which is reviewed and approved annually by the Compensation Committee, and then allocated 50% to RSUs and 50% to PSUs. Dollar amounts for each award type are converted to a number of shares by dividing the dollar amount by the closing price of our stock on the date of grant. The target equity award opportunity for fiscal 2025 as a percentage of annualized base salary for each of our NEOs and the number of RSUs and PSUs awarded to our NEOs is set forth in the following table.
In addition, the Compensation Committee approved an additional one-time RSU grant to one NEO as set forth in the following table. This one-time award was granted based on the Compensation Committee’s review of our peer group and to better align the total compensation of that NEO with market practice in our peer group.
| Fiscal 2025 | Equity Target | Long-Term Equity Award Opportunities | ||||
| Name | Percentage of Base Salary | PSUs (1) | RSUs (2) | One-Time RSUs(3) | ||
| Lee D. Rudow | 150% | 3,925 | 3,925 | — | ||
| Thomas L. Barbato | 125% | 1,918 | 1,919 | — | ||
| Theresa A. Conroy | 65% | 782 | 783 | — | ||
| Michael J. Haddad | 60% | 730 | 730 | — | ||
| Michael W. West | 65% | 916 | 916 | 2,000 | ||
| (1) | The shares underlying the PSUs will vest after three years subject to our achieving specific cumulative Adjusted EBITDA objectives over the eligible three-year period ending in the fiscal year ending March 27, 2027, and subject to the terms of the award and continued employment through the vesting date. |
| (2) | The shares underlying the RSUs will vest on March 27, 2027, subject to the terms of the award and continued employment through the vesting date. |
| (3) | The shares underlying the one-time RSUs for Mr. West will vest on April 11, 2027, subject to the terms of the award and continued employment through the vesting date. |
36
Upon vesting, the holders of PSUs will receive a pro rata percentage based on a linear sliding scale of their respective target number of shares based on the pre-determined cumulative Adjusted EBITDA thresholds:
| · | Maximum cumulative Adjusted EBITDA – 150% |
| · | Target cumulative Adjusted EBITDA – 100% |
| · | Minimum cumulative Adjusted EBITDA – 50% |
Failure to achieve the minimum cumulative Adjusted EBITDA will result in no shares becoming earned under the PSU awards.
The aggregate grant date fair value of the long-term equity incentive awards for our NEOs are reflected in the “Stock Awards” column of the 2025 Summary Compensation Table.
Retirement Benefits
We have established certain retirement benefits for our employees, including our NEOs, which we believe are consistent with our goals of enhancing long-term performance by our employees.
401(k) Plan. Our 401(k) Plan is a tax-qualified defined contribution plan pursuant to which all U.S. based employees, including our NEOs, are eligible to participate. All employees are able to contribute a portion of their annual salary to the plan on a before-tax basis, subject to limitations imposed by the Internal Revenue Service. We currently match 50% of the first 6% of pay that employees contribute to the plan. All participant contributions to the plan are immediately vested and all company matching contributions vest pro rata over a three-year period. The plan contains a discretionary deferred profit sharing component, which, if made, has the same three-year vesting schedule as is applicable to company matching contributions. The amount of company matching contributions under this plan for our NEOs is included in the “All Other Compensation” column of the 2025 Summary Compensation Table.
Non-Qualified Deferred Compensation. Our non-qualified deferred compensation plan allows our executive officers and directors to elect to defer designated percentages or amounts of their compensation. The plan also allows us to make discretionary contributions to the account of a plan participant, which are intended to provide the match that would have been made under our 401(k) Plan but for the limitations imposed on our 401(k) Plan under the Internal Revenue Code. None of our NEOs participate in this plan.
Post-Retirement Health Benefit Plan. The post-retirement health benefit plan for officers is a group health plan that provides benefits to eligible retired officers and their spouses. The original effective date of the plan was December 23, 2006. Three kinds of benefits are provided under the plan: (i) long-term care insurance coverage; (ii) medical and dental insurance coverage; and (iii) medical premium reimbursement benefits. Officers who retire from active employment with us on or after December 23, 2006 at age 55 or older with five or more years of qualifying service and who do not work in any full-time employment (30 hours or more per week) after retirement are eligible to participate in the plan. Qualifying service is described as the individual’s most recent period of continuous, uninterrupted employment with us on or after the individual reaches age 50. Service with a business acquired by us is not counted as qualifying service. As of October 2019, only those individuals who as of July 22, 2019 were “Retirees” as defined in the plan or who are listed on an exhibit to the plan are eligible to participate in the plan. No other individuals are eligible to participate in the plan. None of our NEOs, except Mr. Rudow, is eligible to participate in the plan.
37
2025 Summary Compensation Table
The following table shows certain information about the compensation of our NEOs for our three most recently completed fiscal years.
| Name and Principal Position |
Fiscal Year |
Salary (1) ($) |
Stock Awards (2) ($) |
Option Awards ($) |
Non-Equity Incentive Plan Compensation (3) ($) |
All Other Compensation (4) ($) |
Total ($) |
| Lee D. Rudow | 2025 | 625,861 | 974,400 | – | 194,968 | 20,131 | 1,815,360 |
| President and Chief | 2024 | 639,282 | 1,127,440 | – | 652,700 | 21,038 | 2,440,460 |
| Executive Officer | 2023 | 523,654 | 439,979 | 187,700 | 272,357 | 20,444 | 1,444,134 |
| Thomas L. Barbato | 2025 | 368,410 | 476,250 | – | 67,266 | 10,926 | 922,852 |
| Chief Financial Officer | 2024 | 338,913 | 437,018 | – | 207,691 | 11,207 | 994,829 |
| 2023 | 275,000 | 179,024 | 93,850 | 114,308 | 8,779 | 670,961 | |
| Theresa A. Conroy | 2025 | 289,965 | 194,350 | – | 42,231 | 9,493 | 536,039 |
| Senior Vice President, Human Resources | 2024 | 243,284 | 228,556 | – | 115,933 | 9,194 | 596,967 |
| 2023 | 200,000 | 79,973 | 37,540 | 87,116 | 7,544 | 412,173 | |
| Michael J. Haddad | 2025 | 161,538 | 180,000 | – | 21,186 | 5,002 | 367,727 |
| Chief Information Officer | |||||||
| Michael W. West | 2025 | 344,817 | 441,760 | – | 49,434 | 12,858 | 848,869 |
| Chief Operating Officer | 2024 | 259,693 | 219,765 | – | 129,721 | 10,184 | 619,363 |
| 2023 | 233,746 | 109,979 | – | 71,588 | 10,142 | 425,455 |
| (1) | The amounts shown in this column include cash compensation paid during the applicable fiscal year. |
| (2) | The long-term equity incentive awards granted to our NEOs in fiscal 2025 were granted approximately 50% in RSUs and approximately 50% in PSUs, based on the total fair market value of the awards. The amounts in this column do not reflect the actual value realized by the recipient. The amounts shown in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 (“ASC 718”) for RSUs granted during each fiscal year, except that no estimates for forfeitures have been included. A discussion of the assumptions used to calculate grant date fair value are set forth in Note 6 (Stock-Based Compensation) to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended March 29, 2025. For fiscal 2025, the amounts also include the value of the PSUs based on the probable outcome of the performance conditions as of the date of grant. If the highest level of performance were achieved, the maximum potential value of the fiscal 2025 PSUs for Messrs. Rudow, Barbato, Haddad and West would be $730,757, $357,093, $135,046, and $170,541, respectively, and $145,593 for Ms. Conroy. |
| (3) | The amounts shown in this column reflect amounts earned during the applicable fiscal year under our annual performance-based cash incentive plan. |
| (4) | The amounts shown in this column reflect amounts paid by us in the applicable fiscal year to, or on behalf of, the NEO as Company matching contributions under our 401(k) Plan, executive life insurance premiums and excess long-term disability premiums, long-term care insurance premiums, and financial planning services. The amounts in the All Other Compensation column for fiscal 2025 reflect the following: |
| 401(k) Plan Matches ($) |
Insurance ($) |
Long-term Care Insurance ($) | |
| Lee D. Rudow | 14,238 | 893 | 5,000 |
| Thomas L. Barbato | 10,034 | 893 | – |
| Theresa A. Conroy | 8,633 | 860 | – |
| Michael J. Haddad | 4,500 | 502 | – |
| Michael W. West | 11,972 | 886 | – |
38
Grants of Plan-Based Awards
The following table shows the plan-based awards granted during fiscal 2025 to each of our NEOs:
| Name | Award Type |
Grant Date |
Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1) ($) |
Estimated Future Payouts Under Equity Incentive Plan Awards(2) (#) |
All Other Stock Awards: Number of Shares of Stock or Units (#) |
Grant Date Fair Value of Stock(3) ($) | ||||
| Threshold | Target | Maximum | Threshold | Target | Maximum | |||||
| Lee D. | Annual | 182,213 | 552,160 | 1,104,320 | ||||||
| Rudow | PSUs(4) | 5/21/2024 | 1,963 | 3,925 | 5,888 | 487,171 | ||||
| RSUs(5) | 5/21/2024 | 3,925 | 487,171 | |||||||
| Thomas L. | Annual | 62,865 | 190,500 | 381,000 | ||||||
| Barbato | PSUs(4) | 5/21/2025 | 959 | 1,918 | 2,877 | 238,062 | ||||
| RSUs(5) | 5/21/2024 | 1,919 | 238,186 | |||||||
| Theresa A. | Annual | 39,468 | 119,600 | 239,200 | ||||||
| Conroy | PSUs(4) | 5/21/2024 | 391 | 782 | 1,173 | 97,062 | ||||
| RSUs(5) | 5/21/2024 | 783 | 97,186 | |||||||
| Michael J. | Annual | 39,600 | 120,000 | 240,000 | ||||||
| Haddad | PSUs(4) | 5/21/2024 | 365 | 730 | 1,095 | 90,031 | ||||
| RSUs(5) | 5/21/2024 | 730 | 90,031 | |||||||
| Michael W. | Annual | 46,200 | 140,000 | 280,000 | ||||||
| West | PSUs(4) | 5/21/2024 | 458 | 916 | 1,374 | 113,694 | ||||
| RSUs(5) | 5/21/2024 | 916 | 113,694 | |||||||
| RSUs(6) | 4/11/2024 | 2,000 | 214,260 | |||||||
| (1) | Amounts represent the threshold, target and maximum payout levels for fiscal 2025 under our annual performance-based cash incentive compensation plan. |
| (2) | The shares underlying the PSUs for all NEOs vest after three years subject to our achieving specific cumulative Adjusted EBITDA objectives over the eligible three-year period. |
| (3) | Amounts represent the aggregate grant date fair value of awards pursuant to ASC 718, Compensation – Stock Compensation. Additional details on accounting for stock-based compensation can be found in Note 6 to our consolidated financial statements contained in our annual report on Form 10-K for fiscal 2025. |
| (4) | The PSUs have a three-year performance period (ending on March 27, 2027, the last day of our 2027 fiscal year) subject to our achieving specific cumulative Adjusted EBITDA objectives over the eligible three-year period. The PSUs will vest subject to the performance achieved and continued employment through the vesting date, but may vest pro rata upon the NEO’s earlier death, disability, retirement or termination without cause, including following a change in control of the Company, as described in “Potential Payments upon Termination or Change of Control” below. |
| (5) | Pursuant to the award agreements, these RSUs will vest on March 27, 2027, subject to the grantee’s continued service through the vesting date, but may vest pro rata upon the NEO’s earlier death, disability, retirement or termination without cause, including following a change in control of the Company, as described in “Potential Payments upon Termination or Change of Control” below. |
| (6) | Pursuant to the award agreement, these RSUs will vest on April 11, 2027, subject to the grantee’s continued service through the vesting date, but may vest pro rata earlier upon the NEO’s earlier death, disability, retirement or termination without cause, including following a change in control of the Company, as described in “Potential Payments upon Termination or Change of Control” below. |
39
Outstanding Equity Awards at March 29, 2025
The following table shows information about the number of unexercised stock options and the number and value of unvested restricted stock unit awards held by our NEOs at March 29, 2025.
| Option Awards | Stock Awards | ||||||||||
| Name | Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) Unexercisable |
Option |
Option Expiration Date |
Number of (#) |
Market ($) |
Equity (#) |
Equity ($) | |||
| Lee D. Rudow | – | 10,000 | 63.17 | 5/25/2027 | |||||||
| 3,785 | (2) | 277,743 | |||||||||
| 5,000 | (2) | 366,900 | |||||||||
| 3,925 | (3) | 288,017 | |||||||||
| 3,784 | (4) | 277,670 | |||||||||
| 3,925 | (5) | 288,017 | |||||||||
| Thomas L. Barbato | 6,000 | – | 90.92 | 1/03/2027 | |||||||
| – | 5,000 | 63.17 | 5/25/2027 | ||||||||
| 1,186 | (2) | 87,029 | |||||||||
| 2,500 | (2) | 183,450 | |||||||||
| 1,919 | (3) | 140,816 | |||||||||
| 1,186 | (4) | 87,029 | |||||||||
| 1,918 | (5) | 140,743 | |||||||||
| Theresa A. Conroy | – | 2,000 | 63.17 | 5/25/2027 | |||||||
| 524 | (2) | 38,451 | |||||||||
| 1,500 | (2) | 110,070 | |||||||||
| 783 | (3) | 57,457 | |||||||||
| 524 | (4) | 38,451 | |||||||||
| 782 | (5) | 57,383 | |||||||||
| Michael J. Haddad | 730 | (3) | 53,567 | ||||||||
| 730 | (5) | 53,567 | |||||||||
| Michael W. West | 725 | (2) | 53,201 | ||||||||
| 1,000 | (2) | 73,380 | |||||||||
| 2,000 | (6) | 146,760 | |||||||||
| 916 | (3) | 67,216 | |||||||||
| 725 | (4) | 53,201 | |||||||||
| 916 | (5) | 67,216 | |||||||||
| (1) | Calculated using the closing price of a share of our common stock on March 28, 2025 (the last trading day of fiscal 2025) of $73.38. |
| (2) | These RSUs, which convert into common stock on a one-for-one basis, will vest on March 28, 2026, subject to the grantee’s continued service through each vesting date except as otherwise provided in the applicable award agreement. |
| (3) | These RSUs, which convert into common stock on a one-for-one basis, will vest on March 27, 2027, subject to the grantee’s continued service through each vesting date except as otherwise provided in the applicable award agreement. |
40
(4) | These PSUs will vest after three years subject to the grantee’s continued service through each vesting date except as otherwise provided in the applicable award agreement and our achieving specific cumulative Adjusted EBITDA objectives over the three-year period ending on March 28, 2026. |
| (5) | These PSUs will vest after three years subject to the grantee’s continued service through each vesting date except as otherwise provided in the applicable award agreement and our achieving specific cumulative Adjusted EBITDA objectives over the three-year period ending on March 27, 2027. |
| (6) | These RSUs, which convert into common stock on a one-for-one basis, will vest on April 11, 2027, subject to the grantee’s continued service through each vesting date except as otherwise provided in the applicable award agreement. |
Stock Vested in Fiscal 2025
The following table shows information regarding all stock awards held by our NEOs that vested during fiscal 2025. Other than as provided below, our NEOs did not have any outstanding stock options that vested during fiscal 2025.
| Stock Awards | ||
| Name |
Number of Shares (#) |
Value Realized on ($) |
| Lee D. Rudow | 8,819 | 916,320 |
| Thomas L. Barbato | 2,403 | 225,724 |
| Theresa A. Conroy | 1,074 | 100,902 |
| Michael J. Haddad | – | – |
| Michael W. West | 2,204 | 228,974 |
| (1) | The value realized on vesting is equal to the number of shares vested multiplied by the closing price of a share of our common stock on the vesting date (or if such date falls on a weekend or public holiday, the closing price of a share of our common stock on the date immediately prior to the vesting date on which our shares traded). |
Employment Agreements
During fiscal 2025, we were not a party to any employment agreement with any of our NEOs other than the change-in-control severance agreements with Messrs. Rudow, Barbato and West and Ms. Conroy, as described below.
Potential Payments upon Termination or Change-in-Control
Change-in-Control Severance Agreement. On December 18, 2024, we entered into a change-in-control severance agreement with each of Messrs. Rudow, Barbato and West and Ms. Conroy. For Mr. Rudow, this change-in-control severance agreement replaced a prior change-in-control severance agreement with substantially similar terms. This agreement requires a change in control of our company and a subsequent qualifying termination of the NEO’s employment (often referred to as a “double trigger”) in order to trigger certain payments. The agreement is intended to promote continuity of leadership, maintain the focus of our officers on pursuing any corporate transaction that is in the best interests of our shareholders, and to retain services of our leadership by providing sufficient severance protection during a period of uncertainty.
A change in control occurs under the NEO’s change-in-control severance agreement upon the occurrence of any of the following events: (i) the Company is merged or consolidated with another entity and as a
41
result thereof, less than fifty percent (50%) of the outstanding voting securities of the surviving or resulting entity shall then be owned in the aggregate by the former shareholders of the Company; (ii) as a result, or in connection with, any tender offer or exchange offer, merger or other business combination, or sale or other disposition of assets, or any combination of the foregoing transactions, the individuals who constitute the Board of the Company before any such transaction shall not constitute a majority of the board of directors of the surviving or resulting entity; (iii) a tender offer or exchange offer for the ownership of securities of the Company representing over twenty-five percent (25%) of the combined voting power of the Company’s then outstanding voting securities is made and consummated; (iv) any “person,” including a “group” within the meaning of Section 13(d)(3) of the Exchange Act, but excluding any employee stock ownership plan or similar employee benefit plan of the Company, is or becomes, directly or indirectly, the beneficial owner of securities of the Company representing over twenty-five percent (25%) of the combined voting power of the Company’s then outstanding voting securities; or (v) the Company transfers substantially all of its assets to another corporation that is not a wholly-owned subsidiary of the Company.
In the event of the NEO’s termination due to a change in control, as defined in the agreement, following the agreement for or announcement of a proposed change in control and within 24 months following the effective date of the change in control (the “CIC Period”), the NEO would be entitled to receive the NEO’s full salary, bonus and benefits (to the extent that his continued participation is possible under the general terms and provisions of such plans and programs) as were in effect immediately preceding such change in control. For Messrs. Rudow, Barbato and West and Ms. Conroy this period is 24 months, 12 months and 12 months and 6 months, respectively, following the effective date of the officer’s termination of employment. In addition, the NEO’s outstanding stock options, RSUs and PSUs would immediately vest (with PSUs vesting at the greater of the amount accrued or target) and vested stock options would remain exercisable for the remainder of their term. Pursuant to the agreement, in the event of voluntary termination or termination for certain reasons during the CIC Period, including death, total disability, normal retirement, willful misconduct, gross negligence, breach of duty, unfair competition, conviction of certain crimes, or conduct that disqualifies the officer from employment with the Company, the officer would not be entitled to these amounts or accelerated vesting.
Incentive Plans. For awards granted under our 2021 Stock Incentive Plan, upon a change in control of our company, as defined in the plan, each of our NEOs would be entitled to equivalent replacement or substituted awards for each outstanding award at the time of the change in control. If these awards are not granted, our NEOs would be entitled to immediate vesting of all unvested stock options, stock appreciation rights, and restricted stock awards (with PSUs valued pro-rata assuming target performance). Additionally, if any NEO without a Change-in-Control Severance Agreement is terminated without cause or resigns for good reason within two years immediately following a change in control, the NEO would be entitled to immediate vesting of all awards, with all options and stock appreciation rights remaining exercisable for the shorter of 90 days following such termination or until the expiration of the award pursuant to its stated terms, unless otherwise provided for in the applicable award agreement.
For awards granted under our 2003 Stock Incentive Plan, as amended and restated, upon a change in control of our company, as defined in the plan, each of our NEOs would be entitled to immediate vesting of all unvested stock options and stock awards (with PSUs valued pro-rata assuming target performance).
Post-Retirement Plan. Also, as described above under “Post-Retirement Plan,” upon retirement at age 55 or older after five or more years of continuous service Mr. Rudow is eligible to participate in the post-retirement health benefit plan for officers. No other NEOs are eligible to participate in the plan.
42
Potential Payments Upon Separation
The following table estimates the amount of compensation payable to our NEOs upon separation of employment from the Company for the reasons specified. The calculations assume that the separation was effective as of March 29, 2025, using the closing price of our common stock as of March 28, 2025 (the last trading day of our fiscal year) which was $73.38.
| Annual Compensation per the Summary Compensation Table (1) |
Voluntary Resignation/ Termination |
Death or Disability |
Retirement | Termination without Cause |
Termination in Connection with Change in Control | |||||||
| Lee D. Rudow | ||||||||||||
| Severance Payments (2) | $ | — | $ | — | $ | — | $ | — | $ | 1,299,200 | ||
| Annual Performance-Based Cash Incentive Award (3) | 552,160 | 552,160 | 552,160 | 552,160 | 1,104,320 | |||||||
| Option Awards (4) | 102,100 | 102,100 | 102,100 | 102,100 | 102,100 | |||||||
| PSUs (5) | — | 169,687 | 169,687 | — | 565,686 | |||||||
| RSUs (6) | — | 488,644 | 488,644 | — | 932,660 | |||||||
| Other Benefits | — | — | — | — | 50,000 | |||||||
| Total | $ | 1,815,360 | $ | 654,260 | $ | 1,312,591 | $ | 1,312,591 | $ | 654,260 | $ | 5,464,100 |
| Thomas L. Barbato | ||||||||||||
| Severance Payments (2) | $ | — | $ | — | $ | — | $ | — | $ | 381,000 | ||
| Annual Performance-Based Cash Incentive Award (3) | 190,500 | 190,500 | 190,500 | 190,500 | 190,500 | |||||||
| Option Awards (4) | 51,050 | 51,050 | 51,050 | 51,050 | 51,050 | |||||||
| PSUs (5) | — | 53,184 | 53,184 | — | 227,772 | |||||||
| RSUs (6) | — | 209,838 | 209,838 | — | 411,295 | |||||||
| Other Benefits | — | — | — | — | 10,000 | |||||||
| Total | $ | 992,852 | $ | 241,550 | $ | 504,572 | $ | 504,572 | $ | 241,550 | $ | 1,332,910 |
| Theresa A. Conroy | ||||||||||||
| Severance Payments (2) | $ | — | $ | — | $ | — | $ | — | $ | 149,500 | ||
| Annual Performance-Based Cash Incentive Award (3) | 119,600 | 119,600 | 119,600 | 119,600 | 59,800 | |||||||
| Option Awards (4) | 20,420 | 20,420 | 20,420 | 20,420 | 20,420 | |||||||
| PSUs (5) | — | 23,498 | 23,498 | — | 95,834 | |||||||
| RSUs (6) | — | 109,044 | 109,044 | — | 205,978 | |||||||
| Other Benefits | — | — | — | — | 5,000 | |||||||
| Total | $ | 536,039 | $ | 140,020 | $ | 272,562 | $ | 272,562 | $ | 140,020 | $ | 570,655 |
| Michael J. Haddad | ||||||||||||
| Severance Payments (2) | $ | — | $ | — | $ | — | $ | — | $ | — | ||
| Annual Performance-Based Cash Incentive Award (3) | 120,000 | 120,000 | 120,000 | 120,000 | — | |||||||
| Option Awards (4) | — | — | — | — | — | |||||||
| PSUs (5) | — | — | — | — | 53,567 | |||||||
| RSUs (6) | — | 10,713 | 10,713 | — | 53,567 | |||||||
| Other Benefits | — | — | — | — | — | |||||||
| Total | $ | 367,727 | $ | 120,000 | $ | 130,713 | $ | 130,713 | $ | 120,000 | $ | 1,134,117 |
| Michael W. West | ||||||||||||
| Severance Payments (2) | $ | — | $ | — | $ | — | $ | — | $ | 350,000 | ||
| Annual Performance-Based Cash Incentive Award (3) | 140,000 | 140,000 | 140,000 | 140,000 | 140,000 | |||||||
| Option Awards (4) | — | — | — | — | — | |||||||
| PSUs (5) | — | 32,511 | 32,511 | — | 120,417 | |||||||
| RSUs (6) | — | 143,880 | 143,880 | — | 340,557 | |||||||
| Other Benefits | — | — | — | — | 10,000 | |||||||
| Total | $ | 848,869 | $ | 140,000 | $ | 316,391 | $ | 316,391 | $ | 140,000 | $ | 1,422,976 |
43
| (1) | The amounts in this column are the total reported compensation for fiscal 2025 per the Summary Compensation Table presented earlier in this proxy statement. These amounts are provided for comparative purposes only. |
| (2) | Represent post-employment base salary continuation payments. |
| (3) | Represents the annual performance-based cash incentive award earned as of the assumed termination date. |
| (4) | Represents the value of option awards vested as of the assumed termination date. |
| (5) | Represents the pro-rata value of vested PSUs as of the assumed termination date. For death, disability, or retirement, the value is determined as follows: (i) if the termination date is within the first 15 months of the performance period, shares underlying the PSUs are forfeited; (ii) if the termination date is within months 16 to 27 of the performance period, the pro-rata portion is determined by multiplying the number shares underlying a PSU award by a fraction, the numerator of which is the number of completed months during the vesting period and the denominator of which is 36; and (iii) if the termination date is after 27 months of the performance period, the recipient is eligible to receive the full PSU award. |
| (6) | For death, disability, or retirement, represents the pro-rata value of vested RSUs as of the assumed termination date calculated by multiplying the number shares underlying an RSU award by a fraction, the numerator of which is the number of completed months during the vesting period and the denominator of which is the number of months from the grant date to the vesting date. |
COMPENSATION COMMITTEE REPORT
The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K included in this proxy statement. Based on this review and their discussions, the Compensation Committee has recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement for the Annual Meeting to be filed with the SEC, and also be incorporated by reference in the Company’s annual report on Form 10-K for the fiscal year ended March 29, 2025.
| Compensation Committee: | |
| Craig D. Cairns (Chair) | |
| Dawn G. DePerrior | |
| Oksana S. Dominach | |
| Mbago M. Kaniki |
44
CEO PAY RATIO
For fiscal 2025, the annual total compensation of our Chief Executive Officer, as set forth in the Summary Compensation Table, was $1,815,360, and the annual total compensation of our median employee, other than the Chief Executive Officer, was $64,211. The ratio of the annual total compensation of our Chief Executive Officer to the annual total compensation of our median employee is 28 to 1 (the “pay ratio”).
We determined our median employee based on our worldwide employee population and those employees who were employed as of the last day of fiscal 2025. For purposes of identifying our median employee, we used Form W-2 wages (and the equivalent amounts for our non-U.S. employees) as our consistently applied compensation measure. We did not make cost of living adjustments for the compensation of employees based outside of the U.S. We convert the compensation paid to non-U.S. employees in local currency to U.S. dollars using the applicable exchange rate in effect as of the determination date.
Once we identify our median employee, we calculate their compensation under the Summary Compensation Table rules in a manner that is consistent with the calculation of our Chief Executive Officer’s compensation, without any adjustments or estimates. The SEC requirements for identifying the median employee and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. Accordingly, the pay ratio reported by other companies may not be comparable to the pay ratio reported by us.
PAY VERSUS PERFORMANCE
The following table sets forth the compensation for our principal executive officer (the “PEO”) and the average compensation for our other NEOs (“non-PEO NEOs”), both as reported in the Summary Compensation Table in this proxy statement and with certain adjustments to reflect the “compensation actually paid” to such individuals, as defined under the SEC’s pay versus performance disclosure rules, for each of the past five fiscal years. For further information concerning our pay-for-performance philosophy and how we align executive compensation with our financial performance, refer to the Compensation Discussion and Analysis section in this proxy statement.
|
Fiscal Year |
Summary Compensation Table Total for PEO(1) |
Compensation “Actually Paid” to PEO(2) |
Average Summary Compensation Table Total for non-PEO NEOs(3) |
Average Compensation “Actually Paid” to non- PEO NEOs(4) |
Value of Initial Fixed $100 Investment Based On: |
Net (in thousands) |
Company Selected Measure: Adjusted EBITDA(8) (in thousands) | |
| Company TSR(5) |
Peer Group TSR(6) | |||||||
| 2025 | $ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
| 2024 | $ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
| 2023 | $ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
| 2022 | $ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
| 2021 | $ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
| (1) | Reflects compensation for |
| (2) | The dollar amounts reported in this column represent the amount of “compensation actually paid,” or CAP, to the PEO in the applicable fiscal year, as computed in accordance with the SEC’s pay versus performance disclosure rules. The dollar amounts do not necessarily reflect the actual amount of compensation earned by or paid to the PEO during the applicable fiscal year. The following table provides additional information as to the amounts deducted from and added to the Summary Compensation Table Total for the PEO pursuant to the SEC’s rules to determine CAP to the PEO: |
45
| Fiscal 2025 | ||
| Summary Compensation Table Total for PEO | $ | |
| Adjustments for stock awards and option awards | ||
| (Deduct): Aggregate value for stock awards and option awards included in Summary Compensation Table Total for the covered fiscal year | $ | ( |
| Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end | ||
| Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end | ( | |
| Add: Vesting date fair value of awards granted and vested during the covered fiscal year | ||
| Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year | ( | |
| (Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year | ( | |
| Add: Change in incremental fair value of awards modified during the covered fiscal year | ||
| Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the Summary Compensation Table Total for the covered fiscal year | ||
| Compensation “Actually Paid” to PEO | $ |
| (3) | Reflects the average compensation for the non-PEO NEOs in each applicable fiscal year based on compensation amounts reported in the Summary Compensation Table for the applicable fiscal year. The following table shows the executives who are included as non-PEO NEOs. |
| Executive | 2021 | 2022 | 2023 | 2024 | 2025 |
| Thomas L. Barbato | X | X | X | ||
| Theresa A. Conroy | X | X | X | ||
| Mark A. Doheny | X | X | X | X | |
| Michael J. Haddad | X | ||||
| Michael W. West | X | X | |||
| James M. Jenkins | X | X | X | ||
| Michael J. Tschiderer | X |
| (4) | The dollar amounts reported in this column represent the average amount of CAP to the non-PEO NEOs in the applicable fiscal year, as computed in accordance with the SEC’s pay versus performance disclosure rules. The dollar amounts do not necessarily reflect the actual average amount of compensation earned by or paid to the non-PEO NEOs during the applicable fiscal year. The following table provides additional information as to the amounts deducted from and added to the Average Summary Compensation Table Total for non-PEO NEOs pursuant to the SEC’s rules to determine Average CAP to non-PEO NEOs: |
46
| Fiscal 2025 | ||||
| Summary Compensation Table Total for non-PEO NEOs | $ | |||
| Adjustments for stock awards and option awards | ||||
| (Deduct): Aggregate value for stock awards and option awards included in Summary Compensation Table Total for the covered fiscal year | $ | ( | ) | |
| Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end | ||||
| Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end | ( | ) | ||
| Add: Vesting date fair value of awards granted and vested during the covered fiscal year | ||||
| Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year | ( | ) | ||
| (Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year | ( | ) | ||
| Add: Change in incremental fair value of awards modified during the covered fiscal year | ||||
| Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the Summary Compensation Table Total for the covered fiscal year | ||||
| Compensation “Actually Paid” to non-PEO NEOs | $ | |||
| (5) | Total Shareholder Return, or TSR, reflects the cumulative return of a $100 investment from the beginning of fiscal 2021 through the end of each of the fiscal years in the table, calculated in accordance with Item 201(e) of Regulation S-K. |
| (6) | The index used for this purpose is the S&P Composite 1500 Life Sciences Tools & Services Industry Index. |
| (7) | Reflects Net Income as reported in the Company’s Consolidated Statements of Operations and Comprehensive Income included in the Company’s annual report on Form 10-K for the applicable fiscal year. |
| (8) |
Financial Performance Measures
As discussed in the CD&A, our executive compensation program and compensation decisions reflect the guiding principle of aligning long-term performance with shareholder interests. The metrics used within our incentive plans are selected to support these objectives. The following lists the most important financial performance measures used by the Company during the most recently completed fiscal year. These measures are not listed in order of importance.
| · |
| · |
47
Non-Financial Performance Measure
As discussed in the CD&A, the Board’s assessment of corporate performance was also considered in setting pay-for-performance compensation for fiscal 2025.
Analysis of the Information Presented in the Pay Versus Performance Table
As demonstrated by the following table, the amount of compensation actually paid to Mr. Rudow and the average amount of compensation actually paid to the Company’s NEOs as a group (excluding Mr. Rudow) is aligned with the Company’s cumulative TSR over the five years presented in the table. The table also compares the Company’s cumulative TSR to the TSR of our peer group. The alignment of CAP with the Company’s cumulative TSR over the period presented is because a significant portion of the compensation actually paid to our NEOs is comprised of equity awards. As described in more detail in the section “Compensation Discussion and Analysis – Elements of Executive Compensation,” the Company’s executive compensation program is primarily performance-based, for both short-term incentives (annual cash bonuses) and long-term incentives (equity awards).
CAP and Net Income
As demonstrated by the following table, the amount of compensation actually paid to Mr. Rudow and the average amount of compensation actually paid to the Company’s NEOs as a group (excluding Mr. Rudow) is generally aligned with the Company’s net income over the last five completed fiscal years presented in the table, with the exception of fiscal 2025. During fiscal 2025, while net income increased over fiscal 2024,
48
compensation actually paid to Mr. Rudow and the NEOs as a group (excluding Mr. Rudow) decreased primarily due to the significant decrease in the Company’s stock price.
CAP and Adjusted EBITDA
As demonstrated by the following table, the amount of compensation actually paid to Mr. Rudow and the average amount of compensation actually paid to the Company’s NEOs as a group (excluding Mr. Rudow) is generally aligned with the Company’s Adjusted EBITDA over the last five completed fiscal years presented in the table. As described in more detail in the section “Compensation Discussion and Analysis – Elements of Executive Compensation,” the Company uses Adjusted EBITDA as one of the base corporate objectives to determine awards of performance-based cash incentive compensation. Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure. However, in fiscal 2025, although Adjusted EBITDA increased over fiscal 2024, compensation actually paid to Mr. Rudow and the NEOs as a group (excluding Mr. Rudow) decreased primarily due to the significant decrease in the Company’s stock price.
49
DIRECTOR COMPENSATION
Annual Retainers
We do not pay any director who is also an employee of Transcat or its subsidiaries for their service as director. During fiscal 2025, we changed the compensation structure of our directors as shown in the table below:
| Quarterly Retainer | First and Second Quarters |
Third and Fourth Quarters | ||
| Board Service | 12,500 | 13,750 | ||
| Board Service — Chairman | 7,500 | 15,000 | ||
| Audit Committee Chair | 3,750 | 5,000 | ||
| Compensation Committee Chair | 3,750 | 3,750 | ||
| NESG Committee Chair | 3,750 | 3,750 | ||
| Technology Committee Chair | — | 3,750 | ||
| Executive Committee Member | 2,500 | 2,500 |
In addition, each of our non-employee directors was entitled to an annual grant of time-vesting restricted stock units (“RSUs”) valued at $85,000 that vest after one year. On September 11, 2024, the date of our 2024 annual meeting of shareholders, directors received RSUs for 704 shares of our common stock with a one-year vesting term subject to continued services as a director. The next RSU grant is expected to be made to directors on September 10, 2025, the date of the 2025 annual meeting.
Our non-employee directors are reimbursed for travel and other related expenses incurred in the performance of their duties.
Equity Compensation for Newly-Elected Non-Employee Directors
Newly-elected non-employee directors are eligible to receive a stock option grant of 10,000 shares of common stock pursuant to the Transcat, Inc. 2021 Stock Incentive Plan that vests ratably over five years subject to continued service as a director and has a ten-year term.
Stock Ownership Objective
In order to more closely align the interests of our non-employee directors with the interests of our shareholders, our Corporate Governance Guidelines include a minimum stock ownership objective that requires our directors to work towards acquiring and maintaining a specific level of equity ownership interest in our common stock within a specified time frame. During fiscal 2025, the stock ownership objective for non-employee directors was common stock valued at 3.0 times their annual cash retainer.
We expect new non-employee directors to achieve this stock ownership requirement within five years from the date of their election to the Board. The Compensation Committee monitors the progress made by new non-employee directors in achieving their stock ownership objective.
As of the end of fiscal 2025, each of our non-employee directors was in compliance with our stock ownership objective.
50
Fiscal 2025 Director Compensation Table
The table below shows information about the compensation of our non-employee directors for their service during fiscal 2025.
| Name |
Fees Earned or ($) |
Stock ($) |
Option ($) |
Total ($) | |||||
| Craig D. Cairns | 67,500 | 85,000 | — | 152,500 | |||||
| Dawn G. DePerrior | 52,500 | 85,000 | — | 137,500 | |||||
| Oksana S. Dominach | 80,000 | 85,000 | — | 165,000 | |||||
| Christopher P. Gillette | 52,500 | 85,000 | — | 137,500 | |||||
| Charles P. Hadeed | 62,500 | 85,000 | — | 147,500 | |||||
| Gary J. Haseley | 107,500 | 85,000 | — | 192,500 | |||||
| Mbago M. Kaniki | 67,500 | 85,000 | — | 152,500 | |||||
| Cynthia M. Langston | 60,000 | 85,000 | — | 145,000 | |||||
| Robert L. Mecca | 52,500 | 85,000 | — | 137,500 | |||||
| (1) | The amounts shown include the annual cash board retainer and committee retainers earned by the directors during fiscal 2025. |
| (2) | Includes the aggregate grant date fair value of the RSUs granted during fiscal 2025 as computed in accordance with ASC 718. For each director, the number of RSUs granted was determined by dividing $85,000, the grant date value of the award, by $120.66, the closing price of our common stock on September 10, 2024, the day before the date of grant. |
| (3) | Includes the aggregate grant date fair value of stock options granted during fiscal 2025 as computed in accordance with ASC 718. The table below presents the aggregate number of outstanding stock options for each of our non-employee directors as of March 29, 2025: |
| Name | Number of Shares Underlying Unexercised Options | |
| Craig D. Cairns | 10,000 | |
| Dawn G. DePerrior | 10,000 | |
| Oksana S. Dominach | 10,000 | |
| Christopher P. Gillette | 10,000 | |
| Charles P. Hadeed | — | |
| Gary J. Haseley | — | |
| Mbago M. Kaniki | 10,000 | |
| Cynthia M. Langston | 10,000 | |
| Robert L. Mecca | 10,000 |
51
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The table below presents certain information as of July 14, 2025, about the persons known by us to be the record or beneficial owner of more than 5% of our common stock. Percentages are based on 9,318,490 shares issued and outstanding.
| Name and Address of Beneficial Owner | Number of Shares of Common Stock Beneficially Owned |
Percent of Class | ||
|
BlackRock, Inc. New York, NY 10001 |
598,357 (1) | 6.4% | ||
|
Champlain Investment Partners, LLC Burlington, VT 05401 |
555,650 (2) | 6.0% | ||
|
Conestoga Capital Advisors LLC and 550 E. Swedesford Rd. Suite 120 Wayne, PA 19087 |
972,464 (3) | 10.4% | ||
|
Neuberger Berman Group LLC, et al. 1290 Avenue of the Americas New York, NY 10104 |
932,152 (4) | 10.0% | ||
|
The Vanguard Group 100 Vanguard Blvd. Malvern, PA 19355 |
477,799 (5) | 5.1% | ||
|
T. Rowe Price Investment Management, Inc. 101 E. Pratt Street |
518,597 (6) | 5.6% |
| (1) | This information is based on an amendment to Schedule 13G filed with the SEC on January 26, 2024 by BlackRock, Inc. (“BlackRock”) with respect to shares beneficially owned by it and certain of its subsidiaries. BlackRock reports sole voting power with respect to 587,756 shares and sole dispositive power with respect to 598,357 shares. |
| (2) | This information is based on a Schedule 13G filed with the SEC on February 13, 2025 by Champlain Investment Partners, LLC which reports sole voting power with respect to 379,190 shares and sole dispositive power with respect to 555,650 shares. |
| (3) | This information is based on an amendment to Schedule 13G filed with the SEC on January 10, 2025 by Conestoga Capital Advisors LLC, an investment company, and Conestoga Small Cap Fund. Conestoga Capital Advisors LLC reports sole voting power with respect to 904,926 shares and sole dispositive power with respect to 972,464 shares and Conestoga Small Cap Fund reports sole voting and dispositive power with respect to 643,499 shares. |
| (4) | This information is based on an amendment to Schedule 13G filed with the SEC on February 4, 2025 by Neuberger Berman Group LLC, Neuberger Berman Investment Advisers LLC, Neuberger Berman Equity Funds and Neuberger Berman Genesis Fund. Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC report shared voting power with respect to 912,931 shares and shared dispositive power with respect to 932,152 shares. Neuberger Berman Equity Funds and |
52
|
Neuberger Berman Genesis Fund report shared voting and shared dispositive power with respect to 548,206 shares. |
| (5) | This information is based on a Schedule 13G filed with the SEC on February 13, 2024 by The Vanguard Group which reports shared voting power with respect to 15,777 shares, sole dispositive power over 454,518 shares and shared dispositive power with respect to 23,281 shares. |
| (6) | This information is based on a Schedule 13G filed with the SEC on February 14, 2025 by T. Rowe Price Investment Management, Inc. which reports sole voting and dispositive power with respect to 518,597 shares. |
SECURITY OWNERSHIP OF MANAGEMENT
The table below presents certain information as of July 14, 2025 about shares of our common stock held by (i) each of our directors and director nominees; (ii) each of our named executive officers and (iii) all of our directors, director nominees and executive officers as a group.
| Name of Beneficial Owner | Number of Shares of Common Stock Beneficially Owned (1) |
Percent of Class (1) |
||
| Directors and Director Nominees (other than Rudow) | ||||
| Craig D. Cairns | 15,343 | (2) | * | |
| Dawn G. DePerrior | 2,704 | (3) | * | |
| Oksana S. Dominach | 14,346 | (4) | * | |
| Christopher P. Gillette | 4,704 | (5) | * | |
| Charles P. Hadeed | 22,480 | (6) | * | |
| Gary J. Haseley | 40,302 | (7) | * | |
| Mbago M. Kaniki | 10,593 | (8) | * | |
| Cynthia M. Langston | 7,837 | (9) | * | |
| Robert L. Mecca | 2,704 | (10) | * | |
| Named Executive Officers | ||||
| Lee D. Rudow (11) | 103,864 | (12) | 1.1 | % |
| Thomas L. Barbato | 12,699 | (13) | * | |
| Theresa A. Conroy | 2,836 | (14) | * | |
| Michael J. Haddad | — | — | ||
| Michael W. West | 25,479 | * | ||
| All directors, director nominees and executive officers as a group (14 persons) | 265,891 | (15) | 2.8 | % |
| * | Indicates less than 1%. |
| (1) | The amounts reported by such persons are as of July 14, 2025, with percentages based on 9,318,490 shares issued and outstanding except where the person has the right to receive shares within the next 60 days (as indicated in the other footnotes to this table), which would increase the number of shares owned by such person and the number of shares outstanding. Under the rules of the SEC, “beneficial ownership” is deemed to include shares for which an individual, directly or indirectly, has or shares voting or dispositive power, whether or not they are held for the individual’s benefit, and includes shares that may be acquired within 60 days, including, but not limited to, the right to acquire shares by |
53
| the exercise of options or the vesting of restricted stock units. Shares that may be acquired within 60 days by the exercise of options are referred to in the footnotes to this table as “presently exercisable options” or restricted stock units. Unless otherwise indicated in the other footnotes to this table, each shareholder named in the table has sole voting and sole investment power with respect to all of the shares shown as owned by the shareholder. |
| (2) | Includes 430 shares held by the Howe & Rusling 401(k) Plan FBO Mr. Cairns, 1,910 shares held by Howe & Rusling Roth 401(k) Plan FBO Mr. Cairns, presently exercisable options to purchase 8,000 shares, and 704 restricted stock units. |
| (3) | Includes presently exercisable options to purchase 2,000 shares and 704 restricted stock units. |
| (4) | Includes presently exercisable options to purchase 10,000 shares and 704 restricted stock units. |
| (5) | Includes presently exercisable options to purchase 4,000 shares and 704 restricted stock units. |
| (6) | Includes 704 restricted stock units. |
| (7) | Includes 1,200 shares held by Haseley family trusts and 704 restricted stock units. |
| (8) | Includes presently exercisable options to purchase 8,000 shares and 704 restricted stock units. |
| (9) | Includes presently exercisable options to purchase 6,000 shares and 704 restricted stock units. |
| (10) | Includes presently exercisable options to purchase 2,000 shares and 704 restricted stock units. |
| (11) | Mr. Rudow is also a director. |
| (12) | Includes presently exercisable options to purchase 10,000 shares |
| (13) | Includes presently exercisable options to purchase 11,000 shares. |
| (14) | Includes presently exercisable options to purchase 2,000 shares. |
| (15) | Includes presently exercisable option to purchase 63,000 shares and 6,336 restricted stock units. |
DELINQUENT SECTION 16(a) REPORTS
Section 16(a) of the Exchange Act requires directors, officers and greater than 10% shareholders to file with the SEC reports of ownership and changes in ownership regarding their holdings in company securities. During fiscal 2025, all of our directors and officers timely complied with the filing requirements of Section 16(a) of the Exchange Act, except that Mr. Gillette, a director, filed one late report disclosing one transaction, Mr. Haddad, our Chief Information Officer, filed one late report disclosing one transaction, and Mr. West, our Chief Operating Officer, filed two late reports disclosing one transaction. In making this statement, we have relied upon the written representations of our directors and officers, and copies of the reports that they have filed with the SEC.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Policies and Procedures for Review, Approval or Ratification of Related Person Transactions
Our Board has adopted a written policy for transactions with related persons. Pursuant to the policy, the Audit Committee reviews and, when appropriate, approves any relationships or transactions in which our company and our directors and executive officers or their immediate family members are participants. Existing related person transactions, if any, are reviewed at least annually by the Audit Committee. Any director with an interest in a related person transaction is expected to recuse him or herself from any consideration of the matter.
54
During its review of such relationships and transactions, the Audit Committee considers (i) the nature of the related person’s interest in the transaction; (ii) the material terms of the transaction, including the amount and type of transaction; (iii) the importance of the transaction to the related person and to our company; (iv) whether the transaction would impair the judgment of a director or executive officer to act in the best interest of our company; and (v) any other matters the committee deems appropriate.
In addition, to the extent that the transaction involves an independent director, consideration is also given, as applicable, to the listing standards of the Nasdaq Stock Market and other relevant rules related to independence.
There were no reportable related person transactions during fiscal 2025.
SHAREHOLDER NOMINATIONS AND PROPOSALS FOR THE 2026 ANNUAL MEETING
Proposals Submitted for Inclusion in our Proxy Materials
We will include shareholder proposals that comply with Rule 14a-8 under the Exchange Act in our proxy materials for the 2026 annual meeting of shareholders. Among other things, Rule 14a-8 requires that we receive such proposals no later than 120 days prior to the one-year anniversary of this proxy statement. Thus, for the 2026 annual meeting of shareholders, we must receive shareholder proposals submitted for inclusion in our proxy materials no later than March 26, 2026. Shareholder proposals submitted for inclusion in our proxy materials should be mailed to the following address: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary.
Proposals Not Submitted for Inclusion in our Proxy Materials
Shareholder proposals that are not submitted for inclusion in our proxy materials pursuant to Rule 14a-8 under the Exchange Act, as described above, may be brought before the 2026 annual meeting of shareholders in accordance with Rule 14a-4(c) under the Exchange Act. Pursuant to Rule 14a-4(c), we must receive these proposals no later than 45 days prior to the one-year anniversary of this proxy statement. Thus, for the 2026 annual meeting of shareholders, we must receive shareholder proposals that are not submitted for inclusion in our proxy materials no later than June 9, 2026. In accordance with Rules 14a-4(c) and 14a-8, we will not permit shareholder proposals that do not comply with the foregoing notice requirement to be brought before the 2026 annual meeting of shareholders. Shareholder proposals that are not submitted for inclusion in our proxy statement should be mailed to the following address: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary.
In addition to satisfying the advance notice requirements in order to comply with the universal proxy rules under the Exchange Act, shareholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must also provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than July 13, 2026. Notice should be mailed to the following address: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary.
OTHER MATTERS
As of the date of this proxy statement, the Board does not know of any other matters that are to be presented for action at the Annual Meeting. Should any other matter come before the Annual Meeting, the persons named in the enclosed proxy will have discretionary authority to vote all proxies with respect to the matter in accordance with their judgment.
55
| By Order of the Board of Directors | |
| Thomas L. Barbato | |
| Senior Vice President of Finance and Chief Financial Officer | |
| Rochester, New York | |
| July 24, 2025 |
| We will make available at no cost, upon your written request, a copy of our annual report on Form 10-K for the fiscal year ended March 29, 2025 (without exhibits) as filed with the SEC. Copies of exhibits to our Form 10-K will be made available, upon your written request and payment to us of the reasonable costs of reproduction and mailing, if any. Written requests should be made to: Corporate Secretary, Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624. |
56
APPENDIX A
Adjusted EBITDA Reconciliation
In addition to reporting net income, a U.S. generally accepted accounting (“GAAP”) measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, acquisition related transaction expenses, contingent consideration, and certain other expenses), which is a non-GAAP measure. Our management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and others to evaluate and compare the performance of our core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense and other items, which is not always commensurate with the reporting period in which it is included. As such, our management uses Adjusted EBITDA as a measure of performance when evaluating our business segments and as a basis for planning and forecasting. Adjusted EBITDA is also commonly used by rating agencies, lenders and other parties to evaluate our credit worthiness.
Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute or alternative for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.
| Fiscal Year Ended | ||||||||||||
| March 29, 2025 | March 30, 2024 | March 25, 2023 | ||||||||||
| Net Income | $ | 14,515 | $ | 13,647 | $ | 10,688 | ||||||
| + Interest Expense, net | (27 | ) | 1,027 | 2,417 | ||||||||
| + Other Expense | (425 | ) | 315 | 344 | ||||||||
| + Tax Provision | 3,811 | 4,792 | 2,799 | |||||||||
| Operating Income | 17,874 | 19,781 | 16,248 | |||||||||
| + Depreciation & Amortization | 18,567 | 13,477 | 10,955 | |||||||||
| + Transaction Expense | 1,278 | 1,158 | 185 | |||||||||
| + Other Expense | (1,235 | ) | (315 | ) | (344 | ) | ||||||
| + Noncash Stock Compensation | 3,248 | 4,512 | 3,377 | |||||||||
| Adjusted EBITDA | $ | 39,732 | $ | 38,613 | $ | 30,421 | ||||||
A-1